The Gabelli Healthcare & Wellness Trust NPX Annual report of proxy voting record

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-22021

The Gabelli Healthcare & Wellness^Rx Trust

(Exact name of registrant as specified in charter)

One Corporate Center

Rye, New York 10580-1422

(Address of principal executive offices) (Zip code)

John C. Ball

Gabelli Funds, LLC

One Corporate Center

Rye, New York 10580-1422

(Name and address of agent for service)

Registrant’s telephone number, including area code: 1-800-422-3554

Date of fiscal year end: December 31

Date of reporting period: July 1, 2021 – June 30, 2022

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (17 CFR 239.24 and 274.5), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

PROXY VOTING RECORD

FOR PERIOD JULY 1, 2021 TO JUNE 30, 2022

ProxyEdge

Meeting Date Range: 07/01/2021 - 06/30/2022

The Gabelli Healthcare & Wellness Trust

Report Date: 07/05/2022

Investment Company Report

MCKESSON CORPORATION

Security

58155Q103

Meeting Type

Annual

Ticker Symbol

MCK

Meeting Date

23-Jul-2021

ISIN

US58155Q1031

Agenda

935457425 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a one-year term: Dominic J. Caruso

Management

For

1B.

Election of Director for a one-year term: Donald R. Knauss

Management

For

1C.

Election of Director for a one-year term: Bradley E. Lerman

Management

For

1D.

Election of Director for a one-year term: Linda P. Mantia

Management

For

1E.

Election of Director for a one-year term: Maria Martinez

Management

For

1F.

Election of Director for a one-year term: Edward A. Mueller

Management

For

1G.

Election of Director for a one-year term: Susan R. Salka

Management

For

1H.

Election of Director for a one-year term: Brian S. Tyler

Management

For

1I.

Election of Director for a one-year term: Kenneth E. Washington

Management

For

Ratification of the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending March 31, 2022.

Management

For

Advisory vote on executive compensation.

Management

For

Shareholder proposal on action by written consent of shareholders.

Shareholder

Against

For

ITO EN,LTD.

Security

J25027103

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

27-Jul-2021

ISIN

JP3143000002

Agenda

714422285 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Please reference meeting materials.

Non-Voting

Approve Appropriation of Surplus

Management

For

Appoint a Corporate Auditor Yokokura, Hitoshi

Management

For

HAEMONETICS CORPORATION

Security

405024100

Meeting Type

Annual

Ticker Symbol

HAE

Meeting Date

06-Aug-2021

ISIN

US4050241003

Agenda

935461715 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Christopher A. Simon

For

Robert E. Abernathy

For

Catherine M. Burzik

For

Michael J. Coyle

For

Charles J. Dockendorff

For

Lloyd E. Johnson

For

To approve, on an advisory basis, the compensation of our named executive officers.

Management

For

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 2, 2022.

Management

For

THE J. M. SMUCKER COMPANY

Security

832696405

Meeting Type

Annual

Ticker Symbol

SJM

Meeting Date

18-Aug-2021

ISIN

US8326964058

Agenda

935468264 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director whose term of office will expire in 2022: Susan E. Chapman-Hughes

Management

For

1B.

Election of Director whose term of office will expire in 2022: Paul J. Dolan

Management

For

1C.

Election of Director whose term of office will expire in 2022: Jay L. Henderson

Management

For

1D.

Election of Director whose term of office will expire in 2022: Kirk L. Perry

Management

For

1E.

Election of Director whose term of office will expire in 2022: Sandra Pianalto

Management

For

1F.

Election of Director whose term of office will expire in 2022: Alex Shumate

Management

For

1G.

Election of Director whose term of office will expire in 2022: Mark T. Smucker

Management

For

1H.

Election of Director whose term of office will expire in 2022: Richard K. Smucker

Management

For

1I.

Election of Director whose term of office will expire in 2022: Timothy P. Smucker

Management

For

1J.

Election of Director whose term of office will expire in 2022: Jodi L. Taylor

Management

For

1K.

Election of Director whose term of office will expire in 2022: Dawn C. Willoughby

Management

For

Ratification of appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the 2022 fiscal year.

Management

For

Advisory approval of the Company’s executive compensation.

Management

For

VITASOY INTERNATIONAL HOLDINGS LTD

Security

Y93794108

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

23-Aug-2021

ISIN

HK0345001611

Agenda

714476670 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0714/2021071400452.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0714/2021071400422.pdf

Non-Voting

CMMT

PLEASE NOTE IN THE HONG KONG MARKET THAT A VOTE OF ‘ABSTAIN’ WILL BE TREATED-THE SAME AS A ‘TAKE NO ACTION’ VOTE

Non-Voting

TO RECEIVE AND ADOPT THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31ST MARCH, 2021

Management

For

TO DECLARE A FINAL DIVIDEND

Management

For

3.AI

TO TO RE-ELECT DR. THE HON. SIR DAVID KWOK- PO LI AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR

Management

Against

3.AII

TO RE-ELECT MR. JAN P.S. ERLUND AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR

Management

For

3AIII

TO RE-ELECT MR. ANTHONY JOHN LIDDELL NIGHTINGALE AS AN INDEPENDENT NON- EXECUTIVE DIRECTOR

Management

Against

3.B

TO DETERMINE THE REMUNERATION OF THE DIRECTORS

Management

For

TO APPOINT AUDITORS AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION: KPMG

Management

For

5.A

TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION

Management

Against

5.B

TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY-BACK SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION

Management

For

5.C

TO ADD THE NUMBER OF SHARES BOUGHT-BACK PURSUANT TO RESOLUTION 5B TO THE NUMBER OF SHARES AVAILABLE PURSUANT TO RESOLUTION 5A

Management

Against

CMMT

23 JUL 2021: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF THE-TEXT OF RESOLUTION 3.AI AND RECEIPT OF NAME FOR RESOLUTION 4. IF YOU HAVE-ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO-AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU

Non-Voting

PATTERSON COMPANIES, INC.

Security

703395103

Meeting Type

Annual

Ticker Symbol

PDCO

Meeting Date

13-Sep-2021

ISIN

US7033951036

Agenda

935478506 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director to have terms expiring in 2022: John D. Buck

Management

For

1B.

Election of Director to have terms expiring in 2022: Alex N. Blanco

Management

For

1C.

Election of Director to have terms expiring in 2022: Jody H. Feragen

Management

For

1D.

Election of Director to have terms expiring in 2022: Robert C. Frenzel

Management

For

1E.

Election of Director to have terms expiring in 2022: Francis J. Malecha

Management

For

1F.

Election of Director to have terms expiring in 2022: Ellen A. Rudnick

Management

For

1G.

Election of Director to have terms expiring in 2022: Neil A. Schrimsher

Management

For

1H.

Election of Director to have terms expiring in 2022: Mark S. Walchirk

Management

For

Approval of amendment to Amended and Restated 2015 Omnibus Incentive Plan.

Management

Against

Advisory approval of executive compensation.

Management

For

To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2022.

Management

For

CONAGRA BRANDS, INC.

Security

205887102

Meeting Type

Annual

Ticker Symbol

CAG

Meeting Date

15-Sep-2021

ISIN

US2058871029

Agenda

935479558 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Anil Arora

Management

For

1B.

Election of Director: Thomas K. Brown

Management

For

1C.

Election of Director: Emanuel Chirico

Management

For

1D.

Election of Director: Sean M. Connolly

Management

For

1E.

Election of Director: Joie A. Gregor

Management

For

1F.

Election of Director: Fran Horowitz

Management

For

1G.

Election of Director: Rajive Johri

Management

For

1H.

Election of Director: Richard H. Lenny

Management

For

1I.

Election of Director: Melissa Lora

Management

For

1J.

Election of Director: Ruth Ann Marshall

Management

For

1K.

Election of Director: Craig P. Omtvedt

Management

For

1L.

Election of Director: Scott Ostfeld

Management

For

Ratification of the appointment of KPMG LLP as our independent auditor for fiscal 2022.

Management

For

Advisory approval of our named executive officer compensation.

Management

For

A shareholder proposal regarding written consent.

Shareholder

Against

For

GENERAL MILLS, INC.

Security

370334104

Meeting Type

Annual

Ticker Symbol

GIS

Meeting Date

28-Sep-2021

ISIN

US3703341046

Agenda

935483987 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: R. Kerry Clark

Management

For

1B.

Election of Director: David M. Cordani

Management

For

1C.

Election of Director: Jeffrey L. Harmening

Management

For

1D.

Election of Director: Maria G. Henry

Management

For

1E.

Election of Director: Jo Ann Jenkins

Management

For

1F.

Election of Director: Elizabeth C. Lempres

Management

For

1G.

Election of Director: Diane L. Neal

Management

For

1H.

Election of Director: Steve Odland

Management

For

1I.

Election of Director: Maria A. Sastre

Management

For

1J.

Election of Director: Eric D. Sprunk

Management

For

1K.

Election of Director: Jorge A. Uribe

Management

For

Advisory Vote on Executive Compensation.

Management

For

Ratify Appointment of the Independent Registered Public Accounting Firm.

Management

For

Amendment and Restatement of Our Certificate of Incorporation to Eliminate Supermajority Voting Provisions.

Management

For

INTERSECT ENT, INC.

Security

46071F103

Meeting Type

Special

Ticker Symbol

XENT

Meeting Date

08-Oct-2021

ISIN

US46071F1030

Agenda

935495641 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To adopt the Agreement and Plan of Merger, dated August 6, 2021 (the “Merger Agreement”), by and among Intersect ENT, Inc. (“Intersect ENT”), Medtronic, Inc., and Project Kraken Merger Sub, Inc.

Management

For

To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intersect ENT’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.

Management

For

To adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.

Management

For

CHINA MENGNIU DAIRY CO LTD

Security

G21096105

Meeting Type

ExtraOrdinary General Meeting

Ticker Symbol

Meeting Date

12-Oct-2021

ISIN

KYG210961051

Agenda

714681764 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0923/2021092301214.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0923/2021092301197.pdf

Non-Voting

CMMT

PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- RESOLUTION 1, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING

Non-Voting

THAT: (A) THE PROPOSED RELEVANT SCHEME (INCLUDING BUT NOT LIMITED TO THE ISSUANCE AND SUBSCRIPTION OF THE CONVERTIBLE BONDS, THE LOAN GUARANTEE AND THE SECURITY DEED) BE AND IS HEREBY APPROVED, CONFIRMED AND RATIFIED; (B) THE PLACING AGREEMENT DATED JANUARY 24, 2021 ENTERED INTO BETWEEN THE COMPANY AND THE PLACING AGENT IN RELATION TO THE PLACING OF THE CONVERTIBLE BONDS IN THE AGGREGATE PRINCIPAL AMOUNT OF UP TO HKD EQUIVALENT OF RMB4,000,000,000, A COPY OF THE PLACING AGREEMENT HAVING BEEN PRODUCED TO THE EGM MARKED ’‘B’’ AND SIGNED BY THE CHAIRMAN OF THE EGM FOR IDENTIFICATION PURPOSE, AND THE TRANSACTIONS CONTEMPLATED THEREUNDER BE AND ARE HEREBY APPROVED, CONFIRMED AND RATIFIED; (C) THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS TO BE EXECUTED BY THE COMPANY IN RELATION TO THE ISSUE BY THE COMPANY OF THE CONVERTIBLE BONDS UNDER THE SPECIFIC MANDATE (A COPY OF WHICH HAS BEEN PRODUCED TO THE EGM MARKED ’‘C’’ AND SIGNED BY THE CHAIRMAN OF THE EGM FOR IDENTIFICATION PURPOSE), SUBJECT TO COMPLETION, WHICH ARE CONVERTIBLE AT AN INITIAL CONVERSION PRICE OF HKD 34.73 PER SHARE (SUBJECT TO ADJUSTMENTS) BE AND IS HEREBY APPROVED; (D) THE GRANT OF THE SPECIFIC MANDATE TO THE DIRECTORS TO ISSUE THE CONVERTIBLE BOND SUBJECT TO COMPLETION OF THE PLACING AND TO ISSUE AND ALLOT THE CONVERSION SHARES TO THE NOTES ISSUER BE AND IS HEREBY APPROVED, CONFIRMED AND RATIFIED. THE SPECIFIC MANDATE IS IN ADDITION TO, AND SHALL NOT

Management

For

PREJUDICE NOR REVOKE ANY GENERAL OR SPECIFIC MANDATE(S) WHICH HAS/HAVE BEEN GRANTED OR MAY FROM TIME TO TIME BE GRANTED TO THE DIRECTORS BY THE SHAREHOLDERS PRIOR TO THE PASSING OF THIS RESOLUTION; (E) ANY OTHER DOCUMENTS ENTERED INTO AND/OR TO BE ENTERED INTO IN CONNECTION WITH THE RELEVANT SCHEME AND THE CONVERTIBLE BONDS, INCLUDING BUT NOT LIMITED TO (I) THE FACILITY AGREEMENT, (II) THE SECURITY DEED, (III) THE LOAN GUARANTEE, (IV) THE TRUST DEED AND (V) THE AGENCY AGREEMENT, A COPY OF WHICH HAVING BEEN PRODUCED TO THE EGM MARKED ’‘D’’, ’‘E’’, ’‘F’’, ’‘G’’ AND ’‘H’’, RESPECTIVELY, AND SIGNED BY THE CHAIRMAN OF THE EGM FOR IDENTIFICATION PURPOSE, AND THE TRANSACTIONS CONTEMPLATED THEREUNDER BE AND ARE HEREBY APPROVED, CONFIRMED AND RATIFIED; (F) EACH OF THE DIRECTORS AND THE COMPANY SECRETARY BE AND IS HEREBY AUTHORISED TO DO ALL SUCH ACTS AND THINGS AND SIGN, RATIFY OR EXECUTE (WITH OR WITHOUT AFFIXATION OF SEAL) ALL SUCH DOCUMENTS AND TAKE ALL SUCH STEPS AS SUCH DIRECTOR AND/OR THE COMPANY SECRETARY IN HIS/HER DISCRETION MAY CONSIDER NECESSARY, APPROPRIATE, DESIRABLE AND EXPEDIENT TO IMPLEMENT, GIVE EFFECT TO OR IN CONNECTION WITH THE TRANSACTIONS; AND (G) ANY AND ALL ACTIONS HERETOFORE TAKEN BY ANY DIRECTOR, OFFICER, THE COMPANY SECRETARY AND/OR SHARE REGISTRARS OF THE COMPANY, IN CONNECTION WITH THE FOREGOING RESOLUTIONS, BE AND ARE HEREBY RATIFIED, CONFIRMED AND APPROVED IN ALL RESPECTS

THE PROCTER & GAMBLE COMPANY

Security

742718109

Meeting Type

Annual

Ticker Symbol

Meeting Date

12-Oct-2021

ISIN

US7427181091

Agenda

935488002 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

ELECTION OF DIRECTOR: B. Marc Allen

Management

For

1B.

ELECTION OF DIRECTOR: Angela F. Braly

Management

For

1C.

ELECTION OF DIRECTOR: Amy L. Chang

Management

For

1D.

ELECTION OF DIRECTOR: Joseph Jimenez

Management

For

1E.

ELECTION OF DIRECTOR: Christopher Kempczinski

Management

For

1F.

ELECTION OF DIRECTOR: Debra L. Lee

Management

For

1G.

ELECTION OF DIRECTOR: Terry J. Lundgren

Management

For

1H.

ELECTION OF DIRECTOR: Christine M. McCarthy

Management

For

1I.

ELECTION OF DIRECTOR: Jon R. Moeller

Management

For

1J.

ELECTION OF DIRECTOR: David S. Taylor

Management

For

1K.

ELECTION OF DIRECTOR: Margaret C. Whitman

Management

For

1L.

ELECTION OF DIRECTOR: Patricia A. Woertz

Management

For

Ratify Appointment of the Independent Registered Public Accounting Firm.

Management

For

Advisory Vote to Approve the Company’s Executive Compensation (the “Say on Pay” vote).

Management

For

Shareholder Proposal - Inclusion of Non-Management Employees on Director Nominee Candidate Lists.

Shareholder

Against

For

TRILLIUM THERAPEUTICS INC.

Security

89620X506

Meeting Type

Special

Ticker Symbol

TRIL

Meeting Date

26-Oct-2021

ISIN

CA89620X5064

Agenda

935501723 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To consider and, if deemed advisable, pass, with or without variation, a special resolution, the full text of which is set forth in Appendix B to the accompanying Management Information Circular and Proxy Statement of Trillium dated September 27, 2021 (the “Information Circular”), approving a statutory arrangement (the “Arrangement”) under Division 5 of Part 9 of the Business Corporations Act (British Columbia) involving Trillium, all as more particularly described in the Information Circular.

Management

For

To consider and, if deemed advisable, pass an advisory (non- binding) resolution on specified compensation that may become payable to the named executive officers of Trillium in connection with the Arrangement, all as more particularly described in the Information Circular.

Management

For

CATALENT, INC.

Security

148806102

Meeting Type

Annual

Ticker Symbol

CTLT

Meeting Date

28-Oct-2021

ISIN

US1488061029

Agenda

935494411 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Madhavan Balachandran

Management

For

1B.

Election of Director: Michael J. Barber

Management

For

1C.

Election of Director: J. Martin Carroll

Management

For

1D.

Election of Director: John Chiminski

Management

For

1E.

Election of Director: Rolf Classon

Management

For

1F.

Election of Director: Rosemary A. Crane

Management

For

1G.

Election of Director: John Greisch

Management

For

1H.

Election of Director: Christa Kreuzburg

Management

For

1I.

Election of Director: Gregory T. Lucier

Management

For

1J.

Election of Director: Donald E. Morel, Jr.

Management

For

1K.

Election of Director: Jack Stahl

Management

For

Ratification of Appointment of Independent Auditor for Fiscal 2022.

Management

For

Advisory Vote to Approve Our Executive Compensation (Say-on-Pay).

Management

For

Advisory Vote on the Frequency of Advisory Votes in Respect of Executive Compensation.

Management

1 Year

For

Amend our Certificate of Incorporation to Remove the Limitation on Calling Shareholder Special Meetings.

Management

For

Amend our Certificate of Incorporation to Add a Federal Forum Selection Provision.

Management

For

Amend and Restate our Certificate of Incorporation to (i) Eliminate the Supermajority Vote Requirement for Amendments and (ii) Make Non-Substantive and Conforming Changes.

Management

For

THE HAIN CELESTIAL GROUP, INC.

Security

405217100

Meeting Type

Annual

Ticker Symbol

HAIN

Meeting Date

28-Oct-2021

ISIN

US4052171000

Agenda

935495475 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Richard A. Beck

Management

For

1B.

Election of Director: Celeste A. Clark

Management

For

1C.

Election of Director: Dean Hollis

Management

For

1D.

Election of Director: Shervin J. Korangy

Management

For

1E.

Election of Director: Mark L. Schiller

Management

For

1F.

Election of Director: Michael B. Sims

Management

For

1G.

Election of Director: Glenn W. Welling

Management

For

1H.

Election of Director: Dawn M. Zier

Management

For

Proposal to approve, on an advisory basis, named executive officer compensation.

Management

For

Proposal to ratify the appointment of Ernst & Young LLP to act as registered independent accountants of the Company for the fiscal year ending June 30, 2022.

Management

For

Stockholder proposal to require independent Board Chair.

Shareholder

Against

For

CARDIOVASCULAR SYSTEMS, INC.

Security

141619106

Meeting Type

Annual

Ticker Symbol

CSII

Meeting Date

11-Nov-2021

ISIN

US1416191062

Agenda

935499877 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Class I Director to hold office until the 2024 Annual Meeting: Augustine Lawlor

Management

For

1B.

Election of Class I Director to hold office until the 2024 Annual Meeting: Erik Paulsen

Management

For

To approve a 1,700,000 share increase to the number of shares of the Company’s common stock available for issuance under the Amended and Restated 2017 Equity Incentive Plan.

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2022.

Management

For

To approve, on an advisory basis, the compensation paid to our named executive officers as disclosed in the proxy statement.

Management

For

ELECTROMED, INC.

Security

285409108

Meeting Type

Annual

Ticker Symbol

ELMD

Meeting Date

12-Nov-2021

ISIN

US2854091087

Agenda

935504779 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Stan K. Erickson

For

Gregory J. Fluet

For

Joseph L. Galatowitsch

For

Lee A. Jones

For

Kathleen S. Skarvan

For

Kathleen A. Tune

For

Andrea M. Walsh

For

To ratify appointment of RSM US LLP as our independent registered public accounting firm.

Management

For

To approve, on a non-binding and advisory basis, our executive compensation.

Management

For

CHR. HANSEN HOLDING A/S

Security

K1830B107

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

24-Nov-2021

ISIN

DK0060227585

Agenda

714848821 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

VOTING INSTRUCTIONS FOR MOST MEETINGS ARE CAST BY THE REGISTRAR IN ACCORDANCE-WITH YOUR VOTING INSTRUCTIONS. FOR THE SMALL NUMBER OF MEETINGS WHERE THERE-IS NO REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE CAST BY THE CHAIRMAN OF THE-BOARD (OR A BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A BOARD MEMBER) MAY-CHOOSE TO ONLY CAST PRO-MANAGEMENT VOTING INSTRUCTIONS. TO GUARANTEE YOUR-VOTING INSTRUCTIONS AGAINST MANAGEMENT ARE CAST, YOU MAY SUBMIT A REQUEST TO-ATTEND THE MEETING IN PERSON. THE SUB CUSTODIAN BANKS OFFER REPRESENTATION-SERVICES FOR AN ADDED FEE, IF REQUESTED.

Non-Voting

CMMT

SPLIT AND PARTIAL VOTING IS NOT AUTHORIZED FOR A BENEFICIAL OWNER IN THE-DANISH MARKET.

Non-Voting

CMMT

A BENEFICIAL OWNER SIGNED POWER OF ATTORNEY (POA) IS REQUIRED TO LODGE YOUR- VOTING INSTRUCTIONS. IF NO POA IS SUBMITTED, YOUR INSTRUCTIONS MAY BE-REJECTED.

Non-Voting

CMMT

VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED.

Non-Voting

CMMT

PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN)-WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW-ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE CREST SYSTEM. THIS-TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM.-THE CDIS WILL BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON THE BUSINESS-DAY PRIOR TO MEETING DATE UNLESS OTHERWISE SPECIFIED. IN ORDER FOR A VOTE TO- BE ACCEPTED, THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW-ACCOUNT IN THE CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED-MEMBER/CUSTODIAN

Non-Voting

MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE-THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION-TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR-FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE-SEPARATE INSTRUCTIONS FROM YOU

CMMT

PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘ABSTAIN’-ONLY FOR RESOLUTION NUMBERS 7.A.A, 7.B.A TO 7.B.F AND 8.A. THANK YOU

Non-Voting

REPORT ON THE COMPANY’S ACTIVITIES

Non-Voting

APPROVAL OF THE 2020/21 ANNUAL REPORT

Management

No Action

RESOLUTION ON THE APPROPRIATION OF PROFIT

Management

No Action

PRESENTATION OF THE COMPANY’S 2020/21 REMUNERATION REPORT FOR AN ADVISORY VOTE

Management

No Action

RESOLUTION ON REMUNERATION OF MEMBERS OF THE BOARD OF DIRECTORS

Management

No Action

6.A

PROPOSALS FROM THE BOARD OF DIRECTORS: APPROVAL OF INDEMNIFICATION ARRANGEMENTS AND RELATED AMENDMENT OF THE REMUNERATION POLICY

Management

No Action

7.A.A

ELECTION OF A CHAIR OF THE BOARD OF DIRECTOR: DOMINIQUE REINICHE (RE-ELECTION)

Management

No Action

7.B.A

ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: JESPER BRANDGAARD (RE-ELECTION)

Management

No Action

7.B.B

ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LUIS CANTARELL (RE-ELECTION)

Management

No Action

7.B.C

ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LISE KAAE (RE-ELECTION)

Management

No Action

7.B.D

ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: HEIDI KLEINBACH-SAUTER (RE- ELECTION)

Management

No Action

7.B.E

ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: KEVIN LANE (RE-ELECTION)

Management

No Action

7.B.F

ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LILLIE LI VALEUR (RE-ELECTION)

Management

No Action

8.A

ELECTION OF A COMPANY AUDITOR: RE-ELECTION OF PWC STATSAUTORISERET REVISIONSPARTNERSELSKAB

Management

No Action

AUTHORISATION OF THE CHAIR OF THE ANNUAL GENERAL MEETING

Management

No Action

CMMT

INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE

Non-Voting

CAMPBELL SOUP COMPANY

Security

134429109

Meeting Type

Annual

Ticker Symbol

CPB

Meeting Date

01-Dec-2021

ISIN

US1344291091

Agenda

935506367 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Fabiola R. Arredondo

Management

For

1B.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Howard M. Averill

Management

For

1C.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: John P. (JP) Bilbrey

Management

For

1D.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Mark A. Clouse

Management

For

1E.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Bennett Dorrance

Management

For

1F.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Maria Teresa Hilado

Management

For

1G.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Grant H. Hill

Management

For

1H.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Sarah Hofstetter

Management

For

1I.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Marc B. Lautenbach

Management

For

1J.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Mary Alice D. Malone

Management

For

1K.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Keith R. McLoughlin

Management

For

1L.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Kurt T. Schmidt

Management

For

1M.

Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Archbold D. van Beuren

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2022.

Management

For

To vote on an advisory resolution to approve the fiscal 2021 compensation of our named executive officers, commonly referred to as a “say on pay” vote.

Management

For

To vote on a shareholder proposal regarding simple majority vote.

Shareholder

Against

For

To vote on a shareholder proposal regarding virtual shareholder meetings.

Shareholder

Against

For

MEDTRONIC PLC

Security

G5960L103

Meeting Type

Annual

Ticker Symbol

MDT

Meeting Date

09-Dec-2021

ISIN

IE00BTN1Y115

Agenda

935510429 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director until the 2022 Annual General Meeting: Richard H. Anderson

Management

For

1B.

Election of Director until the 2022 Annual General Meeting: Craig Arnold

Management

For

1C.

Election of Director until the 2022 Annual General Meeting: Scott C. Donnelly

Management

For

1D.

Election of Director until the 2022 Annual General Meeting: Andrea J. Goldsmith, Ph.D.

Management

For

1E.

Election of Director until the 2022 Annual General Meeting: Randall J. Hogan, III

Management

For

1F.

Election of Director until the 2022 Annual General Meeting: Kevin E. Lofton

Management

For

1G.

Election of Director until the 2022 Annual General Meeting: Geoffrey S. Martha

Management

For

1H.

Election of Director until the 2022 Annual General Meeting: Elizabeth G. Nabel, M.D.

Management

For

1I.

Election of Director until the 2022 Annual General Meeting: Denise M. O’Leary

Management

For

1J.

Election of Director until the 2022 Annual General Meeting: Kendall J. Powell

Management

For

Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2022 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration.

Management

For

Approving, on an advisory basis, the Company’s executive compensation.

Management

For

Approving, on an advisory basis, the frequency of Say- on-Pay votes.

Management

1 Year

For

Approving the new 2021 Medtronic plc Long Term Incentive Plan.

Management

Against

Renewing the Board of Directors’ authority to issue shares under Irish law.

Management

For

Renewing the Board of Directors’ authority to opt out of pre- emption rights under Irish law.

Management

Against

Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.

Management

For

VIATRIS INC.

Security

92556V106

Meeting Type

Annual

Ticker Symbol

VTRS

Meeting Date

10-Dec-2021

ISIN

US92556V1061

Agenda

935512219 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Class I Director each to hold office until the 2023 annual meeting: Neil Dimick

Management

For

1B.

Election of Class I Director each to hold office until the 2023 annual meeting: Michael Goettler

Management

For

1C.

Election of Class I Director each to hold office until the 2023 annual meeting: Ian Read

Management

For

1D.

Election of Class I Director each to hold office until the 2023 annual meeting: Pauline van der Meer Mohr

Management

For

Approval, on non-binding advisory basis, of the 2020 compensation of the named executive officers of the Company (the “Say-on-Pay vote”).

Management

For

A non-binding advisory vote on the frequency of the Say- on-Pay vote.

Management

1 Year

For

Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.

Management

For

UNITED NATURAL FOODS, INC.

Security

911163103

Meeting Type

Annual

Ticker Symbol

UNFI

Meeting Date

11-Jan-2022

ISIN

US9111631035

Agenda

935524997 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director to serve until the next annual meeting of stockholders: Eric F. Artz

Management

For

1B.

Election of Director to serve until the next annual meeting of stockholders: Ann Torre Bates

Management

For

1C.

Election of Director to serve until the next annual meeting of stockholders: Gloria R. Boyland

Management

For

1D.

Election of Director to serve until the next annual meeting of stockholders: Denise M. Clark

Management

For

1E.

Election of Director to serve until the next annual meeting of stockholders: J. Alexander Miller Douglas

Management

For

1F.

Election of Director to serve until the next annual meeting of stockholders: Daphne J. Dufresne

Management

For

1G.

Election of Director to serve until the next annual meeting of stockholders: Michael S. Funk

Management

For

1H.

Election of Director to serve until the next annual meeting of stockholders: James L. Muehlbauer

Management

For

1I.

Election of Director to serve until the next annual meeting of stockholders: Peter A. Roy

Management

For

1J.

Election of Director to serve until the next annual meeting of stockholders: Jack Stahl

Management

For

Ratification of the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending July 30, 2022.

Management

For

To approve, on an advisory basis, our executive compensation.

Management

For

BECTON, DICKINSON AND COMPANY

Security

075887109

Meeting Type

Annual

Ticker Symbol

BDX

Meeting Date

25-Jan-2022

ISIN

US0758871091

Agenda

935535128 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Catherine M. Burzik

Management

For

1B.

Election of Director: Carrie L. Byington

Management

For

1C.

Election of Director: R. Andrew Eckert

Management

For

1D.

Election of Director: Claire M. Fraser

Management

For

1E.

Election of Director: Jeffrey W. Henderson

Management

For

1F.

Election of Director: Christopher Jones

Management

For

1G.

Election of Director: Marshall O. Larsen

Management

For

1H.

Election of Director: David F. Melcher

Management

For

1I.

Election of Director: Thomas E. Polen

Management

For

1J.

Election of Director: Claire Pomeroy

Management

For

1K.

Election of Director: Timothy M. Ring

Management

For

1L.

Election of Director: Bertram L. Scott

Management

For

Ratification of the selection of the independent registered public accounting firm.

Management

For

Advisory vote to approve named executive officer compensation.

Management

For

A shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting.

Shareholder

Against

For

MERIDIAN BIOSCIENCE, INC.

Security

589584101

Meeting Type

Annual

Ticker Symbol

VIVO

Meeting Date

26-Jan-2022

ISIN

US5895841014

Agenda

935533910 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

JAMES M. ANDERSON

For

ANTHONY P. BIHL III

For

DWIGHT E. ELLINGWOOD

For

JACK KENNY

For

JOHN C. MCILWRAITH

For

JOHN M. RICE, JR.

For

CATHERINE A. SAZDANOFF

For

FELICIA WILLIAMS

For

Ratification of the appointment of Ernst & Young LLP as Meridian’s independent registered public accounting firm for fiscal year 2022.

Management

For

Approval on an advisory basis of the compensation of named executive officers, as disclosed in the Proxy Statement (“Say-on-Pay” Proposal).

Management

For

POST HOLDINGS, INC.

Security

737446104

Meeting Type

Annual

Ticker Symbol

POST

Meeting Date

27-Jan-2022

ISIN

US7374461041

Agenda

935528767 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Gregory L. Curl

For

Ellen F. Harshman

For

David P. Skarie

For

Ratification of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2022.

Management

For

Advisory approval of the Company’s executive compensation.

Management

For

Approval of the Post Holdings, Inc. 2021 Long-Term Incentive Plan.

Management

For

ARENA PHARMACEUTICALS, INC.

Security

040047607

Meeting Type

Special

Ticker Symbol

ARNA

Meeting Date

02-Feb-2022

ISIN

US0400476075

Agenda

935540888 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To adopt the Agreement and Plan of Merger, dated December 12, 2021 (the “Merger Agreement”), by and among Arena Pharmaceuticals, Inc. (“Arena”), Pfizer Inc., and Antioch Merger Sub, Inc.

Management

For

To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Arena’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.

Management

For

Management

For

EDGEWELL PERSONAL CARE COMPANY

Security

28035Q102

Meeting Type

Annual

Ticker Symbol

EPC

Meeting Date

04-Feb-2022

ISIN

US28035Q1022

Agenda

935534380 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Robert W. Black

Management

For

1B.

Election of Director: George R. Corbin

Management

For

1C.

Election of Director: Carla C. Hendra

Management

For

1D.

Election of Director: John C. Hunter, III

Management

For

1E.

Election of Director: James C. Johnson

Management

For

1F.

Election of Director: Rod R. Little

Management

For

1G.

Election of Director: Joseph D. O’Leary

Management

For

1H.

Election of Director: Rakesh Sachdev

Management

For

1I.

Election of Director: Swan Sit

Management

For

1J.

Election of Director: Gary K. Waring

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2022.

Management

For

To cast a non-binding advisory vote on executive compensation.

Management

For

SURMODICS, INC.

Security

868873100

Meeting Type

Annual

Ticker Symbol

SRDX

Meeting Date

10-Feb-2022

ISIN

US8688731004

Agenda

935536271 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Ronald B. Kalich

For

Gary R. Maharaj

For

Set the number of directors at six (6).

Management

For

Ratify the appointment of Deloitte & Touche LLP as Surmodics’ independent registered public accounting firm for fiscal year 2022.

Management

For

Approve, in a non-binding advisory vote, the Company’s executive compensation.

Management

For

Approve an amendment to the Surmodics, Inc. 2019 Equity Incentive Plan.

Management

Against

BELLRING BRANDS, INC.

Security

079823100

Meeting Type

Annual

Ticker Symbol

BRBR

Meeting Date

11-Feb-2022

ISIN

US0798231009

Agenda

935538136 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Chonda J Nwamu

For

Robert V Vitale

For

Ratification of PricewaterhouseCoopers LLP as the Company’s independent Registered Public Accounting Firm for fiscal year ending September 30, 2022.

Management

For

Say on Pay - An Advisory vote approving executive compensation.

Management

For

Say When on Pay - Advisory vote on the approval of frequency of shareholder votes on Executive Compensation.

Management

1 Year

For

INGLES MARKETS, INCORPORATED

Security

457030104

Meeting Type

Annual

Ticker Symbol

IMKTA

Meeting Date

15-Feb-2022

ISIN

US4570301048

Agenda

935539013 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Ernest E. Ferguson

For

John R. Lowden

For

To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement.

Management

For

Proposal to amend the Company’s Articles of Incorporation.

Management

Against

Stockholder proposal concerning equal voting rights for each share.

Shareholder

Against

For

Stockholder proposal regarding cage free egg progress disclosure.

Shareholder

Abstain

Against

BELLRING BRANDS, INC.

Security

079823100

Meeting Type

Special

Ticker Symbol

BRBR

Meeting Date

08-Mar-2022

ISIN

US0798231009

Agenda

935549660 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To adopt the Transaction Agreement and Plan of Merger, dated as of October 26, 2021 (the “Transaction Agreement”), by and among BellRing Brands, Inc., Post Holdings, Inc., BellRing Distribution, LLC and BellRing Merger Sub Corporation in accordance with its terms and the Delaware General Corporation Law.

Management

For

To adjourn or postpone the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the special meeting to adopt the Transaction Agreement in accordance with its terms and the Delaware General Corporation Law.

Management

For

HOLOGIC, INC.

Security

436440101

Meeting Type

Annual

Ticker Symbol

HOLX

Meeting Date

10-Mar-2022

ISIN

US4364401012

Agenda

935543137 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Stephen P. MacMillan

Management

For

1B.

Election of Director: Sally W. Crawford

Management

For

1C.

Election of Director: Charles J. Dockendorff

Management

For

1D.

Election of Director: Scott T. Garrett

Management

For

1E.

Election of Director: Ludwig N. Hantson

Management

For

1F.

Election of Director: Namal Nawana

Management

For

1G.

Election of Director: Christiana Stamoulis

Management

For

1H.

Election of Director: Amy M. Wendell

Management

For

A non-binding advisory resolution to approve executive compensation.

Management

For

Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2022.

Management

For

AMERISOURCEBERGEN CORPORATION

Security

03073E105

Meeting Type

Annual

Ticker Symbol

ABC

Meeting Date

10-Mar-2022

ISIN

US03073E1055

Agenda

935545016 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Ornella Barra

Management

For

1B.

Election of Director: Steven H. Collis

Management

For

1C.

Election of Director: D. Mark Durcan

Management

For

1D.

Election of Director: Richard W. Gochnauer

Management

For

1E.

Election of Director: Lon R. Greenberg

Management

For

1F.

Election of Director: Jane E. Henney, M.D.

Management

For

1G.

Election of Director: Kathleen W. Hyle

Management

For

1H.

Election of Director: Michael J. Long

Management

For

1I.

Election of Director: Henry W. McGee

Management

For

1J.

Election of Director: Dennis M. Nally

Management

For

Ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2022.

Management

For

Advisory vote to approve the compensation of named executive officers.

Management

For

Approval of the AmerisourceBergen Corporation 2022 Omnibus Incentive Plan.

Management

Against

Stockholder proposal, if properly presented, to adopt a policy that no financial performance metric be adjusted to exclude legal or compliance costs in determining executive compensation.

Shareholder

Abstain

Against

Stockholder proposal, if properly presented, regarding the threshold for calling a special meeting.

Shareholder

Against

For

DLH HOLDINGS CORP.

Security

23335Q100

Meeting Type

Annual

Ticker Symbol

DLHC

Meeting Date

10-Mar-2022

ISIN

US23335Q1004

Agenda

935545143 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

James P. Allen

For

Martin J. Delaney

For

Dr. Elder Granger

For

Dr. Frances M. Murphy

For

Zachary C. Parker

For

Frederick G. Wasserman

For

Austin J. Yerks III

For

Stephen J. Zelkowicz

For

An Advisory Vote regarding the approval of compensation paid to our named Executive Officers.

Management

For

Ratification of Independent Registered Public Accounting Firm.

Management

For

THE COOPER COMPANIES, INC.

Security

216648402

Meeting Type

Annual

Ticker Symbol

COO

Meeting Date

16-Mar-2022

ISIN

US2166484020

Agenda

935545496 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Colleen E. Jay

Management

For

1B.

Election of Director: William A. Kozy

Management

For

1C.

Election of Director: Jody S. Lindell

Management

For

1D.

Election of Director: Teresa S. Madden

Management

For

1E.

Election of Director: Gary S. Petersmeyer

Management

For

1F.

Election of Director: Maria Rivas, M.D.

Management

For

1G.

Election of Director: Robert S. Weiss

Management

For

1H.

Election of Director: Albert G. White III

Management

For

Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for The Cooper Companies, Inc. for the fiscal year ending October 31, 2022.

Management

For

An advisory vote on the compensation of our named executive officers as presented in the Proxy Statement.

Management

For

AGILENT TECHNOLOGIES, INC.

Security

00846U101

Meeting Type

Annual

Ticker Symbol

Meeting Date

16-Mar-2022

ISIN

US00846U1016

Agenda

935546296 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director for a three-year term: Hans E. Bishop

Management

For

1.2

Election of Director for a three-year term: Otis W. Brawley, M.D.

Management

For

1.3

Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D.

Management

For

To approve, on a non-binding advisory basis, the compensation of our named executive officers.

Management

For

To ratify the Audit and Finance Committee’s appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.

Management

For

To vote on a stockholder proposal regarding the right to call a special meeting, if properly presented at the meeting.

Management

Against

For

SUNTORY BEVERAGE & FOOD LIMITED

Security

J78186103

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

25-Mar-2022

ISIN

JP3336560002

Agenda

715213182 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Please reference meeting materials.

Non-Voting

Approve Appropriation of Surplus

Management

For

Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations

Management

For

3.1

Appoint a Director who is not Audit and Supervisory Committee Member Saito, Kazuhiro

Management

For

3.2

Appoint a Director who is not Audit and Supervisory Committee Member Kimura, Josuke

Management

For

3.3

Appoint a Director who is not Audit and Supervisory Committee Member Shekhar Mundlay

Management

For

3.4

Appoint a Director who is not Audit and Supervisory Committee Member Peter Harding

Management

For

3.5

Appoint a Director who is not Audit and Supervisory Committee Member Aritake, Kazutomo

Management

For

3.6

Appoint a Director who is not Audit and Supervisory Committee Member Inoue, Yukari

Management

For

Appoint a Substitute Director who is Audit and Supervisory Committee Member Amitani, Mitsuhiro

Management

For

STANDARD BIOTOOLS INC.

Security

34385P108

Meeting Type

Special

Ticker Symbol

FLDM

Meeting Date

01-Apr-2022

ISIN

US34385P1084

Agenda

935555916 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

The adoption of an amendment to the Company’s Eighth Amended and Restated Certificate of Incorporation (described in the proxy materials accompanying this card) to, among other things, (1) increase the number of shares of common stock, par value $0.001 per share, of the Company that the Company is authorized to issue from two hundred million(200,000,000) shares to four hundred million (400,000,000) shares and (2) change the name of the Company to Standard BioTools Inc.(the “Charter Amendment”).

Management

For

Approval of issuance of (1) Series B-1 Convertible Preferred Stock, par value $0.001 per share, of Company (“Series B-1 Preferred Stock”) and Series B-2 Convertible Preferred Stock, par value $0.001 per share, (the “Series B-2 Preferred Stock”, and together with the Series B-1 Preferred Stock, the “Series B Preferred Stock”) issuable pursuant to the Purchase Agreements (2) Series B-1 Preferred Stock and Series B-2 Preferred Stock issuable pursuant to terms of the Loan Agreements (3) Common stock issuable upon conversion of Series B Preferred Stock.

Management

For

The approval of an adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the Charter Amendment Proposal and the Private Placement Issuance Proposal at the time of the Special Meeting (the “Adjournment Proposal”).

Management

For

NESTLE S.A.

Security

H57312649

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

07-Apr-2022

ISIN

CH0038863350

Agenda

715274635 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR- CUSTODIAN BANK. IF NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY BE REJECTED.

Non-Voting

CMMT

PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 701444 DUE TO CHANGE IN- RECOMMENDATION FOR RESOLUTION 7. ALL VOTES RECEIVED ON THE PREVIOUS MEETING- WILL BE DISREGARDED IF VOTE DEADLINE EXTENSIONS ARE GRANTED. THEREFORE PLEASE- REINSTRUCT ON THIS MEETING NOTICE ON THE NEW JOB. IF HOWEVER VOTE DEADLINE- EXTENSIONS ARE NOT GRANTED IN THE MARKET, THIS MEETING WILL BE CLOSED AND-YOUR VOTE INTENTIONS ON THE ORIGINAL MEETING WILL BE APPLICABLE. PLEASE-ENSURE VOTING IS SUBMITTED PRIOR TO CUTOFF ON THE ORIGINAL MEETING, AND AS-SOON AS POSSIBLE ON THIS NEW AMENDED MEETING. THANK YOU

Non-Voting

CMMT

PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE.THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE

Non-Voting

1.1

APPROVAL OF THE ANNUAL REVIEW, THE FINANCIAL STATEMENTS OF NESTLE S.A. AND THE CONSOLIDATED FINANCIAL STATEMENTS OF THE NESTLE GROUP FOR 2021

Management

No Action

1.2

ACCEPTANCE OF THE COMPENSATION REPORT 2021 (ADVISORY VOTE)

Management

No Action

DISCHARGE TO THE MEMBERS OF THE BOARD OF DIRECTORS AND OF THE MANAGEMENT

Management

No Action

APPROPRIATION OF PROFIT RESULTING FROM THE BALANCE SHEET OF NESTLE S.A. (PROPOSED DIVIDEND) FOR THE FINANCIAL YEAR 2021

Management

No Action

4.1.1

RE-ELECTION AS MEMBER AND CHAIRMAN OF THE BOARD OF DIRECTORS: PAUL BULCKE

Management

No Action

4.1.2

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: ULF MARK SCHNEIDER

Management

No Action

4.1.3

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HENRI DE CASTRIES

Management

No Action

4.1.4

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: RENATO FASSBIND

Management

No Action

4.1.5

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PABLO ISLA

Management

No Action

4.1.6

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: EVA CHENG

Management

No Action

4.1.7

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PATRICK AEBISCHER

Management

No Action

4.1.8

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: KIMBERLY A. ROSS

Management

No Action

4.1.9

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DICK BOER

Management

No Action

4.110

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DINESH PALIWAL

Management

No Action

4.111

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HANNE JIMENEZ DE MORA

Management

No Action

4.112

RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: LINDIWE MAJELE SIBANDA

Management

No Action

4.2.1

ELECTION TO THE BOARD OF DIRECTORS: CHRIS LEONG

Management

No Action

4.2.2

ELECTION TO THE BOARD OF DIRECTORS: LUCA MAESTRI

Management

No Action

4.3.1

ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PABLO ISLA

Management

No Action

4.3.2

ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PATRICK AEBISCHER

Management

No Action

4.3.3

ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DICK BOER

Management

No Action

4.3.4

ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DINESH PALIWAL

Management

No Action

4.4

ELECTION OF THE STATUTORY AUDITORS: ERNST AND YOUNG LTD, LAUSANNE BRANCH

Management

No Action

4.5

ELECTION OF THE INDEPENDENT REPRESENTATIVE: HARTMANN DREYER, ATTORNEYS-AT-LAW

Management

No Action

5.1

APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS

Management

No Action

5.2

APPROVAL OF THE COMPENSATION OF THE EXECUTIVE BOARD

Management

No Action

CAPITAL REDUCTION (BY CANCELLATION OF SHARES)

Management

No Action

IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS: (YES = VOTE IN FAVOR OF ANY SUCH YET UNKNOWN PROPOSAL, NO = VOTE AGAINST ANY SUCH YET UNKNOWN PROPOSAL, ABSTAIN = ABSTAIN FROM VOTING) - THE BOARD OF DIRECTORS RECOMMENDS TO VOTE NO ON ANY SUCH YET UNKNOWN PROPOSAL

Management

No Action

IQVIA HOLDINGS INC.

Security

46266C105

Meeting Type

Annual

Ticker Symbol

IQV

Meeting Date

12-Apr-2022

ISIN

US46266C1053

Agenda

935553710 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

John P. Connaughton

For

John G. Danhakl

For

James A. Fasano

For

Leslie Wims Morris

For

Amendment to Certificate of Incorporation to declassify the Board of Directors over time and provide for the annual election of all directors.

Management

For

Advisory (non-binding) vote to approve executive compensation (say-on-pay).

Management

For

If properly presented, a shareholder proposal regarding majority voting in uncontested director elections.

Management

Against

For

The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.’s independent registered public accounting firm for the year ending December 31, 2022.

Management

For

SMITH & NEPHEW PLC

Security

83175M205

Meeting Type

Annual

Ticker Symbol

SNN

Meeting Date

13-Apr-2022

ISIN

US83175M2052

Agenda

935560448 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To receive the audited accounts

Management

For

To approve the Directors’ Remuneration Report (excluding policy)

Management

For

To declare a final dividend

Management

For

ELECTION AND RE-ELECTION OF DIRECTOR: Erik Engstrom

Management

For

ELECTION AND RE-ELECTION OF DIRECTOR: Robin Freestone

Management

For

ELECTION AND RE-ELECTION OF DIRECTOR: Jo Hallas

Management

For

ELECTION AND RE-ELECTION OF DIRECTOR: John Ma

Management

For

ELECTION AND RE-ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess

Management

For

ELECTION AND RE-ELECTION OF DIRECTOR: Rick Medlock

Management

For

O10

ELECTION AND RE-ELECTION OF DIRECTOR: Deepak Nath

Management

For

O11

ELECTION AND RE-ELECTION OF DIRECTOR: Anne- Françoise Nesmes

Management

For

O12

ELECTION AND RE-ELECTION OF DIRECTOR: Marc Owen

Management

For

O13

ELECTION AND RE-ELECTION OF DIRECTOR: Roberto Quarta

Management

For

O14

ELECTION AND RE-ELECTION OF DIRECTOR: Angie Risley

Management

For

O15

ELECTION AND RE-ELECTION OF DIRECTOR: Bob White

Management

For

O16

To re-appoint the Auditor

Management

For

O17

To authorise Directors’ to determine the remuneration of the Auditor

Management

For

O18

To renew the Directors’ authority to allot shares

Management

For

O19

To approve the Smith+Nephew Sharesave Plan (2022)

Management

For

O20

To approve the Smith+Nephew International Sharesave Plan (2022)

Management

For

S21

To renew the Directors’ authority for the disapplication of the pre-emption rights

Management

Withheld

Against

S22

To authorise the Directors’ to disapply pre-emption rights for the purposes of acquisitions or other capital investments

Management

For

S23

To renew the Directors’ limited authority to make market purchases of the Company’s own shares

Management

For

S24

To authorise general meetings to be held on 14 clear days’ notice

Management

For

IDORSIA LTD

Security

H3879B109

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

14-Apr-2022

ISIN

CH0363463438

Agenda

715221949 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR- CUSTODIAN BANK. IF NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY BE REJECTED.

Non-Voting

CMMT

PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE. THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE

Non-Voting

1.1

ACCEPT FINANCIAL STATEMENTS AND STATUTORY REPORTS

Management

No Action

1.2

APPROVE REMUNERATION REPORT (NON-BINDING)

Management

No Action

APPROVE TREATMENT OF NET LOSS

Management

No Action

APPROVE DISCHARGE OF BOARD AND SENIOR MANAGEMENT

Management

No Action

APPROVE INCREASE IN CONDITIONAL CAPITAL POOL TO CHF 2.8 MILLION TO COVER EXERCISE OF CONVERSION RIGHTS AND/OR WARRANTS

Management

No Action

5.1.1

REELECT MATHIEU SIMON AS DIRECTOR

Management

No Action

5.1.2

REELECT JOERN ALDAG AS DIRECTOR

Management

No Action

5.1.3

REELECT JEAN-PAUL CLOZEL AS DIRECTOR

Management

No Action

5.1.4

REELECT FELIX EHRAT AS DIRECTOR

Management

No Action

5.1.5

REELECT SRISHTI GUPTA AS DIRECTOR

Management

No Action

5.1.6

REELECT PETER KELLOGG AS DIRECTOR

Management

No Action

5.1.7

REELECT SANDY MAHATME AS DIRECTOR

Management

No Action

5.2

REELECT MATHIEU SIMON AS BOARD CHAIRMAN

Management

No Action

5.3.1

REAPPOINT MATHIEU SIMON AS MEMBER OF THE COMPENSATION COMMITTEE

Management

No Action

5.3.2

REAPPOINT FELIX EHRAT AS MEMBER OF THE COMPENSATION COMMITTEE

Management

No Action

5.3.3

REAPPOINT SRISHTI GUPTA AS MEMBER OF THE COMPENSATION COMMITTEE

Management

No Action

6.1

APPROVE REMUNERATION OF DIRECTORS IN THE AMOUNT OF CHF 1.3 MILLION

Management

No Action

6.2

APPROVE REMUNERATION OF EXECUTIVE COMMITTEE IN THE AMOUNT OF CHF 17.22 MILLION

Management

No Action

DESIGNATE BACHMANNPARTNER AG AS INDEPENDENT PROXY

Management

No Action

RATIFY ERNST & YOUNG AG AS AUDITORS

Management

No Action

HCA HEALTHCARE, INC.

Security

40412C101

Meeting Type

Annual

Ticker Symbol

HCA

Meeting Date

21-Apr-2022

ISIN

US40412C1018

Agenda

935561236 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Thomas F. Frist III

Management

For

1B.

Election of Director: Samuel N. Hazen

Management

For

1C.

Election of Director: Meg G. Crofton

Management

For

1D.

Election of Director: Robert J. Dennis

Management

For

1E.

Election of Director: Nancy-Ann DeParle

Management

For

1F.

Election of Director: William R. Frist

Management

For

1G.

Election of Director: Charles O. Holliday, Jr.

Management

For

1H.

Election of Director: Hugh F. Johnston

Management

For

1I.

Election of Director: Michael W. Michelson

Management

For

1J.

Election of Director: Wayne J. Riley, M.D.

Management

For

1K.

Election of Director: Andrea B. Smith

Management

For

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

Advisory vote to approve named executive officer compensation.

Management

For

Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure.

Shareholder

Abstain

Against

Stockholder proposal, if properly presented at the meeting, regarding lobbying disclosure.

Shareholder

Abstain

Against

DANONE SA

Security

F12033134

Meeting Type

MIX

Ticker Symbol

Meeting Date

26-Apr-2022

ISIN

FR0000120644

Agenda

715377289 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

FOR SHAREHOLDERS NOT HOLDING SHARES DIRECTLY WITH A FRENCH CUSTODIAN, VOTING- INSTRUCTIONS WILL BE FORWARDED TO YOUR GLOBAL CUSTODIAN ON VOTE DEADLINE-DATE. THE GLOBAL CUSTODIAN AS THE REGISTERED INTERMEDIARY WILL SIGN THE PROXY-CARD AND FORWARD TO THE LOCAL CUSTODIAN FOR LODGMENT.

Non-Voting

CMMT

FOR FRENCH MEETINGS ‘ABSTAIN’ IS A VALID VOTING OPTION. FOR ANY ADDITIONAL- RESOLUTIONS RAISED AT THE MEETING THE VOTING INSTRUCTION WILL DEFAULT TO-‘AGAINST.’ IF YOUR CUSTODIAN IS COMPLETING THE PROXY CARD, THE VOTING-INSTRUCTION WILL DEFAULT TO THE PREFERENCE OF YOUR CUSTODIAN.

Non-Voting

CMMT

VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED.

Non-Voting

CMMT

07 APR 2022: DUE TO THE COVID19 CRISIS AND IN ACCORDANCE WITH THE PROVISIONS-ADOPTED BY THE FRENCH GOVERNMENT UNDER LAW NO. 2020- 1379 OF NOVEMBER 14,-2020, EXTENDED AND MODIFIED BY LAW NO 2020-1614 OF DECEMBER 18 2020; THE-GENERAL MEETING WILL TAKE PLACE BEHIND CLOSED DOORS WITHOUT THE PHYSICAL- PRESENCE OF SHAREHOLDERS. TO COMPLY WITH THESE LAWS, PLEASE DO NOT SUBMIT ANY- REQUESTS TO ATTEND THE MEETING IN PERSON. THE COMPANY ENCOURAGES ALL-SHAREHOLDERS TO REGULARLY CONSULT THE COMPANY WEBSITE TO VIEW ANY CHANGES TO-THIS POLICY AND PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS-(CDIS) AND PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED-MEMBER/CUSTODIAN) WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT-CDIS TO THE ESCROW ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE-CREST SYSTEM. THIS TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST-SYSTEM DEADLINE. ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN-THE CREST SYSTEM. THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS- PRACTICABLE ON RECORD DATE +1 DAY (OR ON

Non-Voting

MEETING DATE +1 DAY IF NO RECORD-DATE APPLIES) UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS-CONFIRMED AVAILABILIY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED,-THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE-CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED- MEMBER/CUSTODIAN MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE- THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION-TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR- FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE- SEPARATE INSTRUCTIONS FROM YOU

CMMT

PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 712230 DUE TO RECEIPT OF-ADDITION OF RESOLUTION. A. ALL VOTES RECEIVED ON THE PREVIOUS MEETING WILL BE-DISREGARDED AND YOU WILL NEED TO REINSTRUCT ON THIS MEETING NOTICE. THANK YOU

Non-Voting

APPROVAL OF THE CORPORATE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021

Management

No Action

APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021

Management

No Action

ALLOCATION OF INCOME FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 AND SETTING OF THE DIVIDEND AT 1.94 EURO PER SHARE

Management

No Action

RATIFICATION OF THE CO-OPTATION OF VALERIE CHAPOULAUD-FLOQUET AS DIRECTOR, AS A REPLACEMENT FOR ISABELLE SEILLIER, WHO RESIGNED

Management

No Action

APPOINTMENT OF ANTOINE DE SAINT-AFFRIQUE AS DIRECTOR

Management

No Action

APPOINTMENT OF PATRICE LOUVET AS DIRECTOR

Management

No Action

APPOINTMENT OF GERALDINE PICAUD AS DIRECTOR

Management

No Action

APPOINTMENT OF SUSAN ROBERTS AS DIRECTOR

Management

No Action

RENEWAL OF THE TERM OF OFFICE OF ERNST & YOUNG AUDIT AS STATUTORY AUDITOR

Management

No Action

APPOINTMENT OF MAZARS & ASSOCIES AS STATUTORY AUDITOR, AS A REPLACEMENT FOR PRICEWATERHOUSECOOPERS AUDIT FIRM

Management

No Action

APPROVAL OF AN AGREEMENT SUBJECT TO THE PROVISIONS OF ARTICLES L.225-38 AND FOLLOWING OF THE FRENCH COMMERCIAL CODE CONCLUDED BY THE COMPANY WITH VERONIQUE PENCHIENATI-BOSETTA

Management

No Action

APPROVAL OF THE INFORMATION RELATING TO THE REMUNERATION OF CORPORATE OFFICERS MENTIONED IN SECTION I OF ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE FOR THE FINANCIAL YEAR 2021

Management

No Action

APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR 31 DECEMBER 2021 TO VERONIQUE PENCHIENATI-BOSETTA, IN HER CAPACITY AS CHIEF EXECUTIVE OFFICER, BETWEEN 14 MARCH AND 14 SEPTEMBER 2021

Management

No Action

APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR 31 DECEMBER 2021 TO SHANE GRANT, IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER BETWEEN 14 MARCH AND 14 SEPTEMBER 2021

Management

No Action

APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR 31 DECEMBER 2021 TO ANTOINE DE SAINT- AFFRIQUE, CHIEF EXECUTIVE OFFICER AS OF 15 SEPTEMBER 2021

Management

No Action

APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 TO GILLES SCHNEPP, CHAIRMAN OF THE BOARD OF DIRECTORS AS OF 14 MARCH 2021

Management

No Action

APPROVAL OF THE REMUNERATION POLICY FOR EXECUTIVE CORPORATE OFFICERS FOR THE FINANCIAL YEAR 2022

Management

No Action

APPROVAL OF THE REMUNERATION POLICY FOR THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR 2022

Management

No Action

APPROVAL OF THE REMUNERATION POLICY FOR DIRECTORS FOR THE FINANCIAL YEAR 2022

Management

No Action

AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTORS IN ORDER TO PURCHASE, HOLD OR TRANSFER THE COMPANY’S SHARES

Management

No Action

DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH CANCELLATION OF THE PRE-EMPTIVE SUBSCRIPTION RIGHT, RESERVED FOR CATEGORIES OF BENEFICIARIES, CONSISTING OF EMPLOYEES WORKING IN FOREIGN COMPANIES OF THE DANONE GROUP, OR IN A SITUATION OF INTERNATIONAL MOBILITY, IN THE CONTEXT OF EMPLOYEE SHAREHOLDING OPERATIONS

Management

No Action

AUTHORISATION GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH ALLOCATION OF EXISTING PERFORMANCE SHARES OR PERFORMANCE SHARES TO BE ISSUED OF THE COMPANY, WITHOUT THE SHAREHOLDERS’ PRE- EMPTIVE SUBSCRIPTION RIGHT

Management

No Action

AUTHORISATION GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH ALLOCATION OF EXISTING SHARES OR SHARES TO BE ISSUED OF THE COMPANY NOT SUBJECT TO PERFORMANCE CONDITIONS, WITHOUT THE SHAREHOLDERS’ PRE- EMPTIVE SUBSCRIPTION RIGHT

Management

No Action

AMENDMENT TO ARTICLE 19.II OF THE COMPANY’S BY-LAWS RELATING TO THE AGE LIMIT OF THE CHIEF EXECUTIVE OFFICER AND THE DEPUTY CHIEF EXECUTIVE OFFICER

Management

No Action

AMENDMENT TO ARTICLE 18.I OF THE COMPANY’S BY-LAWS RELATING TO THE AGE LIMIT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS

Management

No Action

AMENDMENT TO ARTICLE 17 OF THE COMPANY’S BY-LAWS RELATING TO THE OBLIGATION OF HOLDING SHARES APPLICABLE TO DIRECTORS

Management

No Action

POWERS TO CARRY OUT FORMALITIES

Management

No Action

PLEASE NOT THAT THIS IS A SHAREHOLDER PROPOSAL: AMENDMENT TO PARAGRAPHS I AND III OF ARTICLE 18 OF THE COMPANY’S BY-LAWS ‘THE OFFICE OF THE BOARD - DELIBERATIONS’

Shareholder

No Action

CMMT

07 APR 2022: PLEASE NOTE THAT IMPORTANT ADDITIONAL MEETING INFORMATION IS-AVAILABLE BY CLICKING ON THE MATERIAL URL LINK:- https://fr.ftp.opendatasoft.com/datadila/JO/BALO/pdf/202 2/0404/202204042200706-.pdf AND PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENT. IF-YOU HAVE ALREADY SENT IN YOUR VOTES FOR MID: 720555, PLEASE DO NOT VOTE AGAIN-UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU

Non-Voting

CMMT

Non-Voting

PERKINELMER, INC.

Security

714046109

Meeting Type

Annual

Ticker Symbol

PKI

Meeting Date

26-Apr-2022

ISIN

US7140461093

Agenda

935558811 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a term of one year: Peter Barrett, PhD

Management

For

1B.

Election of Director for a term of one year: Samuel R. Chapin

Management

For

1C.

Election of Director for a term of one year: Sylvie Grégoire, PharmD

Management

For

1D.

Election of Director for a term of one year: Alexis P. Michas

Management

For

1E.

Election of Director for a term of one year: Prahlad R. Singh, PhD

Management

For

1F.

Election of Director for a term of one year: Michel Vounatsos

Management

For

1G.

Election of Director for a term of one year: Frank Witney, PhD

Management

For

1H.

Election of Director for a term of one year: Pascale Witz

Management

For

To ratify the selection of Deloitte & Touche LLP as PerkinElmer’s independent registered public accounting firm for the current fiscal year.

Management

For

To approve, by non-binding advisory vote, our executive compensation.

Management

For

GALAPAGOS N V

Security

36315X101

Meeting Type

Annual

Ticker Symbol

GLPG

Meeting Date

26-Apr-2022

ISIN

US36315X1019

Agenda

935582420 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Amendments to the articles of association as a consequence of the choice for a one-tier board structure, as well as certain other amendments relating to specific matters set out in the articles of association of the Company.

Management

For

As a consequence of and subject to the introduction of a one- tier board structure, appointment of the members of the (former) supervisory board for the remaining term of their mandate as director in the board of directors. ...(due to space limits, see proxy material for full proposal).

Management

For

Proxy for coordination.

Management

For

Authorization to the board of directors.

Management

For

Proxy for the Crossroad Bank for Enterprises, counters for enterprises, registers of the enterprise court, administrative agencies and fiscal administrations.

Management

For

Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2021 and approval of the allocation of the annual result as proposed by the supervisory board.

Management

For

Acknowledgement and approval of the remuneration report.

Management

Against

Acknowledgement and approval of the amended remuneration policy.

Management

Against

Release from liability to be granted to the members of the supervisory board and the statutory auditor for the performance of their duties in the course of the financial year ended on 31 December 2021.

Management

Against

Appointment of Stoffels IMC BV (permanently represented by Mr. Paul Stoffels) as director.

Management

For

A10

Appointment of Jérôme Contamine as independent director.

Management

For

A11

Appointment of Dan Baker as independent director.

Management

For

BIO-RAD LABORATORIES, INC.

Security

090572207

Meeting Type

Annual

Ticker Symbol

BIO

Meeting Date

26-Apr-2022

ISIN

US0905722072

Agenda

935587545 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Melinda Litherland

Management

For

1.2

Election of Director: Arnold A. Pinkston

Management

For

PROPOSAL to ratify the selection of KPMG LLP to serve as the Company’s independent auditors.

Management

For

GALAPAGOS N V

Security

36315X101

Meeting Type

Annual

Ticker Symbol

GLPG

Meeting Date

26-Apr-2022

ISIN

US36315X1019

Agenda

935606319 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Management

For

Management

For

Proxy for coordination.

Management

For

Authorization to the board of directors.

Management

For

Proxy for the Crossroad Bank for Enterprises, counters for enterprises, registers of the enterprise court, administrative agencies and fiscal administrations.

Management

For

Management

For

Acknowledgement and approval of the remuneration report.

Management

Against

Acknowledgement and approval of the amended remuneration policy.

Management

Against

Management

Against

Appointment of Stoffels IMC BV (permanently represented by Mr. Paul Stoffels) as director.

Management

For

A10

Appointment of Jérôme Contamine as independent director.

Management

For

A11

Appointment of Dan Baker as independent director.

Management

For

CALAVO GROWERS, INC.

Security

128246105

Meeting Type

Annual

Ticker Symbol

CVGW

Meeting Date

27-Apr-2022

ISIN

US1282461052

Agenda

935557198 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Farha Aslam

For

Marc L. Brown

For

Michael A. DiGregorio

For

Adriana G. Mendizabal

For

James D. Helin

For

Steven Hollister

For

Kathleen M. Holmgren

For

John M. Hunt

For

J. Link Leavens

For

Donald M. Sanders

For

RATIFICATION OF APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CALAVO GROWERS, INC. FOR THE YEAR ENDING OCTOBER 31, 2022.

Management

For

ADVISORY VOTE APPROVING THE EXECUTIVE COMPENSATION DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT.

Management

For

CIGNA CORPORATION

Security

125523100

Meeting Type

Annual

Ticker Symbol

Meeting Date

27-Apr-2022

ISIN

US1255231003

Agenda

935562911 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: David M. Cordani

Management

For

1B.

Election of Director: William J. DeLaney

Management

For

1C.

Election of Director: Eric J. Foss

Management

For

1D.

Election of Director: Elder Granger, MD, MG, USA (Retired)

Management

For

1E.

Election of Director: Neesha Hathi

Management

For

1F.

Election of Director: George Kurian

Management

For

1G.

Election of Director: Kathleen M. Mazzarella

Management

For

1H.

Election of Director: Mark B. McClellan, MD, PhD

Management

For

1I.

Election of Director: Kimberly A. Ross

Management

For

1J.

Election of Director: Eric C. Wiseman

Management

For

1K.

Election of Director: Donna F. Zarcone

Management

For

Advisory approval of Cigna’s executive compensation.

Management

For

Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna’s independent registered public accounting firm for 2022.

Management

For

Shareholder proposal - Special shareholder meeting improvement.

Shareholder

Against

For

Shareholder proposal - Gender pay gap report.

Shareholder

Abstain

Against

Shareholder proposal - Political contributions report.

Shareholder

Abstain

Against

VERICEL CORPORATION

Security

92346J108

Meeting Type

Annual

Ticker Symbol

VCEL

Meeting Date

27-Apr-2022

ISIN

US92346J1088

Agenda

935564915 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Robert L. Zerbe

For

Alan L. Rubino

For

Heidi Hagen

For

Steven C. Gilman

For

Kevin F. McLaughlin

For

Paul K. Wotton

For

Dominick C. Colangelo

For

Lisa Wright

For

To approve, on an advisory basis, the compensation of Vericel Corporation’s named executive officers.

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve the adoption of Vericel Corporation’s 2022 Omnibus Incentive Plan.

Management

Against

SEMA4 HOLDINGS CORP.

Security

81663L101

Meeting Type

Special

Ticker Symbol

SMFR

Meeting Date

27-Apr-2022

ISIN

US81663L1017

Agenda

935602854 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

The Stock Consideration Issuance Proposal - For purposes of complying with applicable Nasdaq Stock Market (the “Nasdaq”) listing rules (the “Nasdaq Listing Rules”), to approve the issuance of the Company’s Class A common stock, par value $0.0001 per share (the “Class A common stock”), in connection with the Acquisition (as defined in the accompanying Proxy Statement) of GeneDx, Inc. as contemplated by the Agreement and Plan of Merger and Reorganization dated January 14, 2022 (the “Merger Agreement”)

Management

For

The PIPE Investment Proposal - For purposes of complying with the Nasdaq Listing Rules, to approve the issuance of the Class A common stock in connection with the PIPE Investment (as defined in the accompanying proxy statement) and as contemplated by the Subscription Agreements (as define in the accompanying proxy statement).

Management

For

The Special Designee Director Election Proposal - Assuming the Stock Consideration Issuance Proposal and the Charter Amendment Proposal are approved and adopted and the Acquisition is consummated, to appoint two directors who will become directors of the Company effective upon the consummation of the Acquisition.

Management

For

The Charter Amendment Proposal - To adopt an Amendment (the “Amendment”) to the Third Amended and Restated Certificate of Incorporation of the Company, in the form attached hereto as Annex B (the “Charter”), which increases the number of authorized shares of Class A common stock from 380,000,000 to 1,000,000,000.

Management

For

The Class I Director Election Proposal - To elect three Class I directors of the Company, each to serve a three- year term expiring at the Company’s 2025 annual meeting of stockholders and until such director’s successor is duly elected and qualified.

Management

For

The Auditor Ratification Proposal - To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Adjournment Proposal - To approve, if necessary, the adjournment of the Special Meeting to a later date or dates to permit further solicitation and votes of proxies in the event that there are insufficient votes for, or otherwise in connection with any of the proposals presented at the Special Meeting.

Management

For

KERRY GROUP PLC

Security

G52416107

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

28-Apr-2022

ISIN

IE0004906560

Agenda

715303943 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED

Non-Voting

CMMT

PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE-SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE PROVIDING THE UNDERLYING-SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON-HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE-SPEAK TO YOUR DEDICATED CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE”

Non-Voting

TO REVIEW THE COMPANY’S AFFAIRS AND TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021, TOGETHER WITH THE REPORTS OF THE DIRECTORS AND THE AUDITORS THEREON

Management

No Action

TO DECLARE A FINAL DIVIDEND AS RECOMMENDED BY THE DIRECTORS

Management

No Action

03A

TO ELECT THE FOLLOWING DIRECTOR: MS FIONA DAWSON

Management

No Action

03B

TO ELECT THE FOLLOWING DIRECTOR: MR MICHAEL KERR

Management

No Action

04A

TO RE-ELECT THE FOLLOWING DIRECTOR: MR GERRY BEHAN

Management

No Action

04B

TO RE-ELECT THE FOLLOWING DIRECTOR: DR HUGH BRADY

Management

No Action

04C

TO RE-ELECT THE FOLLOWING DIRECTOR: DR KARIN DORREPAAL

Management

No Action

04D

TO RE-ELECT THE FOLLOWING DIRECTOR: MS EMER GILVARRY

Management

No Action

04E

TO RE-ELECT THE FOLLOWING DIRECTOR: MS MARGUERITE LARKIN

Management

No Action

04F

TO RE-ELECT THE FOLLOWING DIRECTOR: MR TOM MORAN

Management

No Action

04G

TO RE-ELECT THE FOLLOWING DIRECTOR: MR CHRISTOPHER ROGERS

Management

No Action

04H

TO RE-ELECT THE FOLLOWING DIRECTOR: MR EDMOND SCANLON

Management

No Action

04I

TO RE-ELECT THE FOLLOWING DIRECTOR: MR JINLONG WANG

Management

No Action

TO AUTHORISE THE DIRECTORS TO DETERMINE THE REMUNERATION OF THE AUDITORS

Management

No Action

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING ORDINARY RESOLUTION: THAT UNTIL OTHERWISE DETERMINED BY THE COMPANY IN GENERAL MEETING THE NON-EXECUTIVE DIRECTORS BE PAID AS FEES IN RESPECT OF EACH YEAR COMMENCING WITH THE YEAR ENDED 31 DECEMBER 2022 SUCH SUM NOT EXCEEDING EUR 2,000,000 IN AGGREGATE IN ANY YEAR, AS THE DIRECTORS SHALL DETERMINE, WHICH SUM SHALL BE DIVIDED AMONGST THEM IN SUCH PROPORTION AS THEY SHALL DETERMINE

Management

No Action

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING ORDINARY RESOLUTION: TO RECEIVE AND CONSIDER THE DIRECTORS’ REMUNERATION REPORT (OTHER THAN THE REMUNERATION POLICY IN SECTION C) AS SET OUT ON PAGES 121 TO 151 OF THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

Management

No Action

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING ORDINARY RESOLUTION: THAT THE DIRECTORS BE AND ARE HEREBY GENERALLY AND UNCONDITIONALLY AUTHORISED TO EXERCISE ALL THE POWERS OF THE COMPANY TO ALLOT RELEVANT SECURITIES (WITHIN THE MEANING OF SECTION 1021 OF THE COMPANIES ACT, 2014), TO INCLUDE THE REISSUE OF TREASURY SHARES, IF ANY, PROVIDED THAT: - THE MAXIMUM AMOUNT OF RELEVANT SECURITIES WHICH MAY BE ALLOTTED UNDER THIS AUTHORITY SHALL NOT EXCEED AN AGGREGATE NOMINAL AMOUNT OF EUR 2,500,000; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION WILL EXPIRE ON THE EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY MAY BEFORE SUCH EXPIRY MAKE AN OFFER OR AGREEMENT WHICH WOULD OR MIGHT REQUIRE RELEVANT SECURITIES TO BE ALLOTTED AFTER SUCH EXPIRY, AND THE DIRECTORS MAY ALLOT RELEVANT SECURITIES IN PURSUANCE OF SUCH OFFER OR AGREEMENT, AS IF SUCH AUTHORITY HAD NOT EXPIRED

Management

No Action

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: SUBJECT TO RESOLUTION 8 HEREIN BEING PASSED, THAT THE DIRECTORS BE AND ARE HEREBY EMPOWERED PURSUANT TO ARTICLE 5 OF THE ARTICLES OF ASSOCIATION OF THE COMPANY AND SECTIONS 1022 AND 1023 OF THE COMPANIES ACT, 2014 TO ALLOT EQUITY SECURITIES (WITHIN THE MEANING

Management

No Action

OF THE SAID SECTION 1023) FOR CASH, TO INCLUDE THE REISSUE OF TREASURY SHARES, IF ANY, AS IF SECTION 1022(1) OF THE SAID ACT DID NOT APPLY TO ANY SUCH ALLOTMENT, PROVIDED THAT: - THIS POWER SHALL BE LIMITED TO ALLOTMENTS OF UP TO AN AGGREGATE NOMINAL AMOUNT OF EUR 1,105,313 AND ALLOTMENTS IN CONNECTION WITH OR PURSUANT TO ANY RIGHTS ISSUE, OPEN OFFER OR OTHER INVITATION TO OR IN FAVOUR OF HOLDERS OF SHARES IN THE COMPANY IN PROPORTION AS NEARLY AS MAY BE TO SUCH HOLDERS’ HOLDINGS OF SUCH SHARES, SUBJECT TO SUCH LIMITS, EXCLUSIONS, ADJUSTMENTS OR OTHER ARRANGEMENTS AS THE DIRECTORS CONSIDER EXPEDIENT IN RELATION TO TREASURY SHARES, FRACTIONAL ENTITLEMENTS, RECORD DATES, LEGAL, REGULATORY OR PRACTICAL PROBLEMS UNDER THE LAWS OF OR THE REQUIREMENTS OF ANY RELEVANT REGULATORY BODY, SECURITIES MARKET OR STOCK EXCHANGE, IN ANY TERRITORY, OR ANY MATTER WHATSOEVER; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION WILL EXPIRE ON THE EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY MAY BEFORE SUCH EXPIRY MAKE AN OFFER OR AGREEMENT WHICH WOULD OR MIGHT REQUIRE EQUITY SECURITIES TO BE ALLOTTED AFTER SUCH EXPIRY, AND THE DIRECTORS MAY ALLOT EQUITY SECURITIES IN PURSUANCE OF SUCH AN OFFER OR AGREEMENT AS IF SUCH POWER HAD NOT EXPIRED

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: THAT SUBJECT TO RESOLUTIONS 8 AND 9 HEREIN BEING PASSED, THE DIRECTORS BE AND ARE HEREBY EMPOWERED PURSUANT TO SECTIONS 1022 AND 1023 OF THE COMPANIES ACT, 2014 TO ALLOT EQUITY SECURITIES (WITHIN THE MEANING OF THE SAID SECTION 1023) FOR CASH, TO INCLUDE THE REISSUE OF TREASURY SHARES, IF ANY, AS IF SECTION 1022(1) OF THE SAID ACT DID NOT APPLY TO ANY SUCH ALLOTMENT, PROVIDED THAT: - THIS POWER SHALL BE LIMITED TO ALLOTMENTS OF ADDITIONAL SHARES UP TO AN AGGREGATE NOMINAL AMOUNT OF EUR 1,105,313 IN CONNECTION WITH AN ACQUISITION OR SPECIFIED CAPITAL INVESTMENT WHICH IS ANNOUNCED CONTEMPORANEOUSLY WITH THE ALLOTMENT, OR WHICH WILL HAVE TAKEN PLACE IN THE PRECEDING SIX-MONTH PERIOD AND IS DISCLOSED IN THE ANNOUNCEMENT OF THE ALLOTMENT; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION SHALL EXPIRE ON THE

Management

No Action

EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY MAY BEFORE SUCH EXPIRY MAKE AN OFFER OR AGREEMENT WHICH WOULD OR MIGHT REQUIRE EQUITY SECURITIES TO BE ALLOTTED AFTER SUCH EXPIRY, AND THE DIRECTORS MAY ALLOT EQUITY SECURITIES IN PURSUANCE OF SUCH AN OFFER OR AGREEMENT AS IF SUCH POWER HAD NOT EXPIRED

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: THAT THE COMPANY (AND ANY SUBSIDIARY OF THE COMPANY) BE AND IS HEREBY AUTHORISED TO MAKE MARKET PURCHASES AND OVERSEAS MARKET PURCHASES (AS DEFINED IN SECTION 1072 OF THE COMPANIES ACT, 2014 AND TO INCLUDE MAKING A CONTRACT OF PURCHASE WHICH IS OR MAY BE EXECUTED WHOLLY OR PARTLY AFTER THE EXPIRY OF THIS AUTHORITY) OF A ORDINARY SHARES IN THE CAPITAL OF THE COMPANY IN THE MANNER PROVIDED FOR AND WITHIN THE PRICE RANGES SET OUT IN THE ARTICLES OF ASSOCIATION OF THE COMPANY PROVIDED THAT: - THE MAXIMUM NUMBER OF A ORDINARY SHARES WHICH MAY BE ACQUIRED UNDER THIS AUTHORITY SHALL NOT EXCEED 5% OF THE A ORDINARY SHARES IN ISSUE AT THE DATE OF THE PASSING OF THIS RESOLUTION; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION SHALL EXPIRE ON THE EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY (OR ANY SUBSIDIARY) MAY MAKE SUCH A PURCHASE AFTER SUCH EXPIRY PURSUANT TO A CONTRACT OF PURCHASE CONCLUDED BEFORE SUCH EXPIRY

Management

No Action

TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: THAT THE MEMORANDUM OF ASSOCIATION OF THE COMPANY DATED 28 APRIL 2022, WHICH HAS BEEN AVAILABLE FOR INSPECTION AT THE REGISTERED OFFICE OF THE COMPANY, AND ON THE COMPANY’S WEBSITE SINCE THE DATE OF THE NOTICE OF THIS ANNUAL GENERAL MEETING, BE AND IS HEREBY APPROVED AND ADOPTED AS THE NEW MEMORANDUM OF ASSOCIATION OF THE COMPANY IN SUBSTITUTION FOR, AND TO THE EXCLUSION OF, THE EXISTING MEMORANDUM OF ASSOCIATION OF THE COMPANY

Management

No Action

CMMT

19 APR 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO CHANGE OF THE RECORD-DATE FROM 22 APR 2022 TO 24 APR 2022 AND CHANGE IN NUMBERING. IF YOU HAVE-ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO-AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU

Non-Voting

INTUITIVE SURGICAL, INC.

Security

46120E602

Meeting Type

Annual

Ticker Symbol

ISRG

Meeting Date

28-Apr-2022

ISIN

US46120E6023

Agenda

935560765 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Craig H. Barratt, Ph.D.

Management

For

1B.

Election of Director: Joseph C. Beery

Management

For

1C.

Election of Director: Gary S. Guthart, Ph.D.

Management

For

1D.

Election of Director: Amal M. Johnson

Management

For

1E.

Election of Director: Don R. Kania, Ph.D.

Management

For

1F.

Election of Director: Amy L. Ladd, M.D.

Management

For

1G.

Election of Director: Keith R. Leonard, Jr.

Management

For

1H.

Election of Director: Alan J. Levy, Ph.D.

Management

For

1I.

Election of Director: Jami Dover Nachtsheim

Management

For

1J.

Election of Director: Monica P. Reed, M.D.

Management

For

1K.

Election of Director: Mark J. Rubash

Management

For

To approve, by advisory vote, the compensation of the Company’s Named Executive Officers.

Management

For

The ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve the Company’s Amended and Restated 2010 Incentive Award Plan.

Management

Against

PFIZER INC.

Security

717081103

Meeting Type

Annual

Ticker Symbol

PFE

Meeting Date

28-Apr-2022

ISIN

US7170811035

Agenda

935562062 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Ronald E. Blaylock

Management

For

1B.

Election of Director: Albert Bourla

Management

For

1C.

Election of Director: Susan Desmond-Hellmann

Management

For

1D.

Election of Director: Joseph J. Echevarria

Management

For

1E.

Election of Director: Scott Gottlieb

Management

For

1F.

Election of Director: Helen H. Hobbs

Management

For

1G.

Election of Director: Susan Hockfield

Management

For

1H.

Election of Director: Dan R. Littman

Management

For

1I.

Election of Director: Shantanu Narayen

Management

For

1J.

Election of Director: Suzanne Nora Johnson

Management

For

1K.

Election of Director: James Quincey

Management

For

1L.

Election of Director: James C. Smith

Management

For

Ratify the selection of KPMG LLP as independent registered public accounting firm for 2022

Management

For

2022 advisory approval of executive compensation

Management

For

Shareholder proposal regarding amending proxy access

Shareholder

Against

For

Shareholder proposal regarding report on political expenditures congruency

Shareholder

Abstain

Against

Shareholder proposal regarding report on transfer of intellectual property to potential COVID-19 manufacturers

Shareholder

Abstain

Against

Shareholder proposal regarding report on board oversight of risks related to anticompetitive practices

Shareholder

Against

For

Shareholder proposal regarding report on public health costs of protecting vaccine technology

Shareholder

Abstain

Against

JOHNSON & JOHNSON

Security

478160104

Meeting Type

Annual

Ticker Symbol

JNJ

Meeting Date

28-Apr-2022

ISIN

US4781601046

Agenda

935562997 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Darius Adamczyk

Management

For

1B.

Election of Director: Mary C. Beckerle

Management

For

1C.

Election of Director: D. Scott Davis

Management

For

1D.

Election of Director: Ian E. L. Davis

Management

For

1E.

Election of Director: Jennifer A. Doudna

Management

For

1F.

Election of Director: Joaquin Duato

Management

For

1G.

Election of Director: Alex Gorsky

Management

For

1H.

Election of Director: Marillyn A. Hewson

Management

For

1I.

Election of Director: Hubert Joly

Management

For

1J.

Election of Director: Mark B. McClellan

Management

For

1K.

Election of Director: Anne M. Mulcahy

Management

For

1L.

Election of Director: A. Eugene Washington

Management

For

1M.

Election of Director: Mark A. Weinberger

Management

For

1N.

Election of Director: Nadja Y. West

Management

For

Advisory Vote to Approve Named Executive Officer Compensation.

Management

For

Approval of the Company’s 2022 Long-Term Incentive Plan.

Management

Against

Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2022.

Management

For

Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw).

Shareholder

Abstain

Civil Rights, Equity, Diversity & Inclusion Audit Proposal.

Shareholder

Abstain

Against

Third Party Racial Justice Audit.

Shareholder

Abstain

Against

Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics.

Shareholder

Abstain

Against

Report on Public Health Costs of Protecting Vaccine Technology.

Shareholder

Abstain

Against

10.

Discontinue Global Sales of Baby Powder Containing Talc.

Shareholder

Abstain

Against

11.

Request for Charitable Donations Disclosure.

Shareholder

Abstain

Against

12.

Third Party Review and Report on Lobbying Activities Alignment with Position on Universal Health Coverage.

Shareholder

Abstain

Against

13.

Adopt Policy to Include Legal and Compliance Costs in Incentive Compensation Metrics.

Shareholder

Abstain

Against

14.

CEO Compensation to Weigh Workforce Pay and Ownership.

Shareholder

Abstain

Against

CHURCH & DWIGHT CO., INC.

Security

171340102

Meeting Type

Annual

Ticker Symbol

CHD

Meeting Date

28-Apr-2022

ISIN

US1713401024

Agenda

935566779 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director to serve for a term of one year: Bradlen S. Cashaw

Management

For

1B.

Election of Director to serve for a term of one year: James R. Craigie

Management

For

1C.

Election of Director to serve for a term of one year: Matthew T. Farrell

Management

For

1D.

Election of Director to serve for a term of one year: Bradley C. Irwin

Management

For

1E.

Election of Director to serve for a term of one year: Penry W. Price

Management

For

1F.

Election of Director to serve for a term of one year: Susan G. Saideman

Management

For

1G.

Election of Director to serve for a term of one year: Ravichandra K. Saligram

Management

For

1H.

Election of Director to serve for a term of one year: Robert K. Shearer

Management

For

1I.

Election of Director to serve for a term of one year: Janet S. Vergis

Management

For

1J.

Election of Director to serve for a term of one year: Arthur B. Winkleblack

Management

For

1K.

Election of Director to serve for a term of one year: Laurie J. Yoler

Management

For

An advisory vote to approve compensation of our named executive officers.

Management

For

Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2022.

Management

For

Proposal to approve an amendment and restatement of the Church & Dwight Co., Inc. Amended and Restated Omnibus Equity Compensation Plan.

Management

For

Stockholder Proposal - Special Shareholder Meeting Improvement.

Shareholder

Against

For

KELLOGG COMPANY

Security

487836108

Meeting Type

Annual

Ticker Symbol

Meeting Date

29-Apr-2022

ISIN

US4878361082

Agenda

935557720 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director (term expires 2025): Rod Gillum

Management

For

1B.

Election of Director (term expires 2025): Mary Laschinger

Management

For

1C.

Election of Director (term expires 2025): Erica Mann

Management

For

1D.

Election of Director (term expires 2025): Carolyn Tastad

Management

For

Advisory resolution to approve executive compensation.

Management

For

Ratification of the appointment of PricewaterhouseCoopers LLP as Kellogg’s independent registered public accounting firm for fiscal year 2022.

Management

For

Management proposal to approve the Kellogg Company 2022 Long-Term Incentive Plan.

Management

For

Shareowner proposal for CEO compensation to weigh workforce pay and ownership, if properly presented at the meeting.

Shareholder

Abstain

Against

ABBOTT LABORATORIES

Security

002824100

Meeting Type

Annual

Ticker Symbol

ABT

Meeting Date

29-Apr-2022

ISIN

US0028241000

Agenda

935562909 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

R. J. Alpern

For

S. E. Blount

For

R. B. Ford

For

P. Gonzalez

For

M. A. Kumbier

For

D. W. McDew

For

N. McKinstry

For

W. A. Osborn

For

M. F. Roman

For

D. J. Starks

For

J. G. Stratton

For

G. F. Tilton

For

Ratification of Ernst & Young LLP As Auditors

Management

For

Say on Pay - An Advisory Vote on the Approval of Executive Compensation

Management

For

Shareholder Proposal - Special Shareholder Meeting Threshold

Shareholder

Against

For

Shareholder Proposal - Independent Board Chairman

Shareholder

Against

For

Shareholder Proposal - Rule 10b5-1 Plans

Shareholder

Against

For

Shareholder Proposal - Lobbying Disclosure

Shareholder

Abstain

Against

Shareholder Proposal - Antimicrobial Resistance Report

Shareholder

Against

For

ASTRAZENECA PLC

Security

046353108

Meeting Type

Annual

Ticker Symbol

AZN

Meeting Date

29-Apr-2022

ISIN

US0463531089

Agenda

935582317 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021

Management

For

To confirm dividends

Management

For

To reappoint PricewaterhouseCoopers LLP as Auditor

Management

For

To authorise the Directors to agree the remuneration of the Auditor

Management

For

5A.

Re-election of Director: Leif Johansson

Management

For

5B.

Re-election of Director: Pascal Soriot

Management

For

5C.

Election of Director: Aradhana Sarin

Management

For

5D.

Re-election of Director: Philip Broadley

Management

For

5E.

Re-election of Director: Euan Ashley

Management

For

5F.

Re-election of Director: Michel Demaré

Management

For

5G.

Re-election of Director: Deborah DiSanzo

Management

For

5H.

Re-election of Director: Diana Layfield

Management

For

5I.

Re-election of Director: Sheri McCoy

Management

For

5J.

Re-election of Director: Tony Mok

Management

For

5K.

Re-election of Director: Nazneen Rahman

Management

For

5L.

Election of Director: Andreas Rummelt

Management

For

5M.

Re-election of Director: Marcus Wallenberg

Management

For

To approve the Annual Report on Remuneration for the year ended 31 December 2021

Management

For

To authorise limited political donations

Management

For

To authorise the Directors to allot shares

Management

For

To authorise the Directors to disapply pre-emption rights (Special Resolution)

Management

Abstain

Against

10.

To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)

Management

For

11.

To authorise the Company to purchase its own shares (Special Resolution)

Management

For

12.

To reduce the notice period for general meetings (Special Resolution)

Management

For

13.

To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme

Management

For

ASTRAZENECA PLC

Security

046353108

Meeting Type

Annual

Ticker Symbol

AZN

Meeting Date

29-Apr-2022

ISIN

US0463531089

Agenda

935608729 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021

Management

For

To confirm dividends

Management

For

To reappoint PricewaterhouseCoopers LLP as Auditor

Management

For

To authorise the Directors to agree the remuneration of the Auditor

Management

For

5A.

Re-election of Director: Leif Johansson

Management

For

5B.

Re-election of Director: Pascal Soriot

Management

For

5C.

Election of Director: Aradhana Sarin

Management

For

5D.

Re-election of Director: Philip Broadley

Management

For

5E.

Re-election of Director: Euan Ashley

Management

For

5F.

Re-election of Director: Michel Demaré

Management

For

5G.

Re-election of Director: Deborah DiSanzo

Management

For

5H.

Re-election of Director: Diana Layfield

Management

For

5I.

Re-election of Director: Sheri McCoy

Management

For

5J.

Re-election of Director: Tony Mok

Management

For

5K.

Re-election of Director: Nazneen Rahman

Management

For

5L.

Election of Director: Andreas Rummelt

Management

For

5M.

Re-election of Director: Marcus Wallenberg

Management

For

To approve the Annual Report on Remuneration for the year ended 31 December 2021

Management

For

To authorise limited political donations

Management

For

To authorise the Directors to allot shares

Management

For

To authorise the Directors to disapply pre-emption rights (Special Resolution)

Management

Abstain

Against

10.

To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)

Management

For

11.

To authorise the Company to purchase its own shares (Special Resolution)

Management

For

12.

To reduce the notice period for general meetings (Special Resolution)

Management

For

13.

To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme

Management

For

BAXTER INTERNATIONAL INC.

Security

071813109

Meeting Type

Annual

Ticker Symbol

BAX

Meeting Date

03-May-2022

ISIN

US0718131099

Agenda

935566630 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: José (Joe) Almeida

Management

For

1B.

Election of Director: Thomas F. Chen

Management

For

1C.

Election of Director: Peter S. Hellman

Management

For

1D.

Election of Director: Michael F. Mahoney

Management

For

1E.

Election of Director: Patricia B. Morrison

Management

For

1F.

Election of Director: Stephen N. Oesterle

Management

For

1G.

Election of Director: Nancy M. Schlichting

Management

For

1H.

Election of Director: Cathy R. Smith

Management

For

1I.

Election of Director: Albert P.L. Stroucken

Management

For

1J.

Election of Director: Amy A. Wendell

Management

For

1K.

Election of Director: David S. Wilkes

Management

For

Advisory Vote to Approve Named Executive Officer Compensation

Management

For

Ratification of Appointment of Independent Registered Public Accounting Firm

Management

For

Vote to Approve a Certificate of Incorporation Amendment to Permit Stockholder Action by Written Consent

Management

For

Vote to Approve a Certificate of Incorporation Amendment to Lower the Special Meeting Threshold

Management

For

Stockholder Proposal - Special Shareholder Meeting Improvement

Shareholder

Against

For

Stockholder Proposal - Independent Board Chairman

Shareholder

Against

For

BRISTOL-MYERS SQUIBB COMPANY

Security

110122108

Meeting Type

Annual

Ticker Symbol

BMY

Meeting Date

03-May-2022

ISIN

US1101221083

Agenda

935571782 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A)

Election of Director: Peter J. Arduini

Management

For

1B)

Election of Director: Giovanni Caforio, M.D.

Management

For

1C)

Election of Director: Julia A. Haller, M.D.

Management

For

1D)

Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.

Management

For

1E)

Election of Director: Paula A. Price

Management

For

1F)

Election of Director: Derica W. Rice

Management

For

1G)

Election of Director: Theodore R. Samuels

Management

For

1H)

Election of Director: Gerald L. Storch

Management

For

1I)

Election of Director: Karen H. Vousden, Ph.D.

Management

For

1J)

Election of Director: Phyllis R. Yale

Management

For

Advisory Vote to Approve the Compensation of our Named Executive Officers.

Management

For

Ratification of the Appointment of an Independent Registered Public Accounting Firm.

Management

For

Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%.

Shareholder

Against

For

Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director.

Shareholder

Against

For

MAPLE LEAF FOODS INC

Security

564905107

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

04-May-2022

ISIN

CA5649051078

Agenda

715382660 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

07 APR 2022: PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR-‘AGAINST’ ONLY FOR RESOLUTION 3 AND ‘IN FAVOR’ OR ‘ABSTAIN’ ONLY FOR-RESOLUTION NUMBERS 1.1 TO 1.10 AND 2. THANK YOU.

Non-Voting

1.1

ELECTION OF DIRECTOR: WILLIAM E. AZIZ

Management

For

1.2

ELECTION OF DIRECTOR: W. GEOFFREY BEATTIE

Management

For

1.3

ELECTION OF DIRECTOR: RONALD G. CLOSE

Management

For

1.4

ELECTION OF DIRECTOR: JEAN M. FRASER

Management

For

1.5

ELECTION OF DIRECTOR: THOMAS P. HAYES

Management

For

1.6

ELECTION OF DIRECTOR: TIMOTHY D. HOCKEY

Management

For

1.7

ELECTION OF DIRECTOR: KATHERINE N. LEMON

Management

For

1.8

ELECTION OF DIRECTOR: JONATHAN W.F. MCCAIN

Management

For

1.9

ELECTION OF DIRECTOR: MICHAEL H. MCCAIN

Management

For

1.10

ELECTION OF DIRECTOR: CAROL M. STEPHENSON

Management

For

APPOINTMENT OF KPMG LLP, AS AUDITORS OF MAPLE LEAF FOODS INC. FOR THE ENSUING YEAR AND AUTHORIZING THE DIRECTORS TO FIX THEIR REMUNERATION

Management

For

TO APPROVE, ON AN ADVISORY AND NON-BINDING BASIS, MAPLE LEAF FOODS INC.’S APPROACH TO EXECUTIVE COMPENSATION

Management

For

CMMT

07 APR 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF-COMMENT. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN-UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU

Non-Voting

INTERNATIONAL FLAVORS & FRAGRANCES INC.

Security

459506101

Meeting Type

Annual

Ticker Symbol

IFF

Meeting Date

04-May-2022

ISIN

US4595061015

Agenda

935567163 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Kathryn J. Boor

Management

For

1B.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Edward D. Breen

Management

For

1C.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Barry A. Bruno

Management

For

1D.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Frank Clyburn

Management

For

1E.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Carol Anthony Davidson

Management

For

1F.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Michael L. Ducker

Management

For

1G.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Roger W. Ferguson, Jr.

Management

For

1H.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: John F. Ferraro

Management

For

1I.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Christina Gold

Management

For

1J.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Ilene Gordon

Management

For

1K.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Matthias J. Heinzel

Management

For

1L.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Dale F. Morrison

Management

For

1M.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Kåre Schultz

Management

For

1N.

Election of Director for a one-year term expiring at the 2023 Annual Meeting: Stephen Williamson

Management

For

Ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2022 fiscal year.

Management

For

Approve, on an advisory basis, the compensation of our named executive officers in 2021.

Management

For

PEPSICO, INC.

Security

713448108

Meeting Type

Annual

Ticker Symbol

PEP

Meeting Date

04-May-2022

ISIN

US7134481081

Agenda

935567997 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Segun Agbaje

Management

For

1B.

Election of Director: Shona L. Brown

Management

For

1C.

Election of Director: Cesar Conde

Management

For

1D.

Election of Director: Ian Cook

Management

For

1E.

Election of Director: Edith W. Cooper

Management

For

1F.

Election of Director: Dina Dublon

Management

For

1G.

Election of Director: Michelle Gass

Management

For

1H.

Election of Director: Ramon L. Laguarta

Management

For

1I.

Election of Director: Dave Lewis

Management

For

1J.

Election of Director: David C. Page

Management

For

1K.

Election of Director: Robert C. Pohlad

Management

For

1L.

Election of Director: Daniel Vasella

Management

For

1M.

Election of Director: Darren Walker

Management

For

1N.

Election of Director: Alberto Weisser

Management

For

Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for fiscal year 2022.

Management

For

Advisory approval of the Company’s executive compensation.

Management

For

Shareholder Proposal - Independent Board Chairman.

Shareholder

Against

For

Shareholder Proposal - Report on Global Public Policy and Political Influence Outside the U.S.

Shareholder

Abstain

Against

Shareholder Proposal - Report on Public Health Costs.

Shareholder

Abstain

Against

CONFORMIS, INC.

Security

20717E101

Meeting Type

Annual

Ticker Symbol

CFMS

Meeting Date

04-May-2022

ISIN

US20717E1010

Agenda

935568204 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Mark A. Augusti

For

Carrie Bienkowski

For

Gary P. Fischetti

For

To approve an amendment to the Company’s restated certificate of incorporation to effect a reverse stock split of our common stock.

Management

For

To approve the compensation of the Company’s named executive officers.

Management

For

To ratify the selection of Grant Thornton LLP as Conformis’ independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

STRYKER CORPORATION

Security

863667101

Meeting Type

Annual

Ticker Symbol

SYK

Meeting Date

04-May-2022

ISIN

US8636671013

Agenda

935568711 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A)

Election of Director: Mary K. Brainerd

Management

For

1B)

Election of Director: Giovanni Caforio, M.D.

Management

For

1C)

Election of Director: Srikant M. Datar, Ph.D.

Management

For

1D)

Election of Director: Allan C. Golston (Lead Independent Director)

Management

For

1E)

Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President)

Management

For

1F)

Election of Director: Sherilyn S. McCoy

Management

For

1G)

Election of Director: Andrew K. Silvernail

Management

For

1H)

Election of Director: Lisa M. Skeete Tatum

Management

For

1I)

Election of Director: Ronda E. Stryker

Management

For

1J)

Election of Director: Rajeev Suri

Management

For

Ratification of Appointment of our Independent Registered Public Accounting Firm.

Management

For

Advisory Vote to Approve Named Executive Officer Compensation.

Management

For

Shareholder Proposal to Amend Proxy Access Terms.

Shareholder

Abstain

Against

GILEAD SCIENCES, INC.

Security

375558103

Meeting Type

Annual

Ticker Symbol

GILD

Meeting Date

04-May-2022

ISIN

US3755581036

Agenda

935570134 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Jacqueline K. Barton, Ph.D.

Management

For

1B.

Election of Director: Jeffrey A. Bluestone, Ph.D.

Management

For

1C.

Election of Director: Sandra J. Horning, M.D.

Management

For

1D.

Election of Director: Kelly A. Kramer

Management

For

1E.

Election of Director: Kevin E. Lofton

Management

For

1F.

Election of Director: Harish Manwani

Management

For

1G.

Election of Director: Daniel P. O’Day

Management

For

1H.

Election of Director: Javier J. Rodriguez

Management

For

1I.

Election of Director: Anthony Welters

Management

For

To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.

Management

For

To approve the Gilead Sciences, Inc. 2022 Equity Incentive Plan.

Management

Against

To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.

Shareholder

Against

For

To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board include one member from Gilead’s non-management employees.

Shareholder

Against

For

To vote on a stockholder proposal, if properly presented at the meeting, requesting a 10% threshold to call a special stockholder meeting.

Shareholder

Against

For

To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board publish a third- party review of Gilead’s lobbying activities.

Shareholder

Abstain

Against

To vote on a stockholder proposal, if properly presented at the meeting, requesting a Board report on oversight of risks related to anticompetitive practices.

Shareholder

Abstain

Against

UNILEVER PLC

Security

904767704

Meeting Type

Annual

Ticker Symbol

Meeting Date

04-May-2022

ISIN

US9047677045

Agenda

935580010 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To receive the Report and Accounts for the year ended 31 December 2021.

Management

For

To approve the Directors’ Remuneration Report.

Management

For

To re-elect Mr N Andersen as a Non-Executive Director.

Management

For

To re-elect Dr J Hartmann as a Non-Executive Director.

Management

For

To re-elect Mr A Jope as an Executive Director.

Management

For

To re-elect Ms A Jung as a Non-Executive Director.

Management

For

To re-elect Ms S Kilsby as a Non-Executive Director.

Management

For

To re-elect Mr S Masiyiwa as a Non-Executive Director.

Management

For

To re-elect Professor Y Moon as a Non-Executive Director.

Management

For

10.

To re-elect Mr G Pitkethly as an Executive Director.

Management

For

11.

To re-elect Mr F Sijbesma as a Non-Executive Director.

Management

For

12.

To elect Mr A Hennah as a Non-Executive Director.

Management

For

13.

To elect Mrs R Lu as a Non-Executive Director.

Management

For

14.

To reappoint KPMG LLP as Auditors of the Company.

Management

For

15.

To authorise the Directors to fix the remuneration of the Auditors.

Management

For

16.

To authorise Political Donations and expenditure.

Management

For

17.

To renew the authority to Directors to issue shares.

Management

For

18.

To renew the authority to Directors to disapply pre- emption rights.

Management

Abstain

Against

19.

To renew the authority to Directors to disapply pre- emption rights for the purposes of acquisitions or capital investments.

Management

For

20.

To renew the authority to the Company to purchase its own shares.

Management

For

21.

To shorten the notice period for General Meetings.

Management

For

THE KRAFT HEINZ COMPANY

Security

500754106

Meeting Type

Annual

Ticker Symbol

KHC

Meeting Date

05-May-2022

ISIN

US5007541064

Agenda

935569561 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Gregory E. Abel

Management

For

1B.

Election of Director: John T. Cahill

Management

For

1C.

Election of Director: João M. Castro-Neves

Management

For

1D.

Election of Director: Lori Dickerson Fouché

Management

For

1E.

Election of Director: Timothy Kenesey

Management

For

1F.

Election of Director: Alicia Knapp

Management

For

1G.

Election of Director: Elio Leoni Sceti

Management

For

1H.

Election of Director: Susan Mulder

Management

For

1I.

Election of Director: James Park

Management

For

1J.

Election of Director: Miguel Patricio

Management

For

1K.

Election of Director: John C. Pope

Management

For

Advisory vote to approve executive compensation.

Management

For

Advisory vote on the frequency of holding an advisory vote to approve executive compensation.

Management

1 Year

For

Ratification of the selection of PricewaterhouseCoopers LLP as our independent auditors for 2022.

Management

For

Stockholder Proposal - Report on water risk, if properly presented.

Shareholder

Abstain

Against

BOSTON SCIENTIFIC CORPORATION

Security

101137107

Meeting Type

Annual

Ticker Symbol

BSX

Meeting Date

05-May-2022

ISIN

US1011371077

Agenda

935569941 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Nelda J. Connors

Management

For

1B.

Election of Director: Charles J. Dockendorff

Management

For

1C.

Election of Director: Yoshiaki Fujimori

Management

For

1D.

Election of Director: Donna A. James

Management

For

1E.

Election of Director: Edward J. Ludwig

Management

For

1F.

Election of Director: Michael F. Mahoney

Management

For

1G.

Election of Director: David J. Roux

Management

For

1H.

Election of Director: John E. Sununu

Management

For

1I.

Election of Director: David S. Wichmann

Management

For

1J.

Election of Director: Ellen M. Zane

Management

For

To approve, on a non-binding, advisory basis, named executive officer compensation.

Management

For

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2022 fiscal year.

Management

For

To approve an amendment and restatement of our 2006 Global Employee Stock Ownership Plan (to be renamed as our Employee Stock Purchase Plan), as previously amended and restated, including a request for 10,000,000 additional shares.

Management

For

PERRIGO COMPANY PLC

Security

G97822103

Meeting Type

Annual

Ticker Symbol

PRGO

Meeting Date

06-May-2022

ISIN

IE00BGH1M568

Agenda

935567339 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Bradley A. Alford

Management

For

1B.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Orlando D. Ashford

Management

For

1C.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Katherine C. Doyle

Management

For

1D.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Adriana Karaboutis

Management

For

1E.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Murray S. Kessler

Management

For

1F.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Jeffrey B. Kindler

Management

For

1G.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Erica L. Mann

Management

For

1H.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Donal O’Connor

Management

For

1I.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Geoffrey M. Parker

Management

For

1J.

Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Theodore R. Samuels

Management

For

Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company’s independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor

Management

For

Advisory vote on executive compensation

Management

For

Amend the Company’s Long-Term Incentive Plan

Management

For

Renew the Board’s authority to issue shares under Irish law

Management

For

Renew the Board’s authority to opt-out of statutory pre- emption rights under Irish law

Management

Against

ABBVIE INC.

Security

00287Y109

Meeting Type

Annual

Ticker Symbol

ABBV

Meeting Date

06-May-2022

ISIN

US00287Y1091

Agenda

935568141 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

William H.L. Burnside

For

Thomas C. Freyman

For

Brett J. Hart

For

Edward J. Rapp

For

Ratification of Ernst & Young LLP as AbbVie’s independent registered public accounting firm for 2022

Management

For

Say on Pay - An advisory vote on the approval of executive compensation

Management

For

Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting

Management

For

Stockholder Proposal - to Adopt a Policy to Require Independent Chairman

Shareholder

Against

For

Stockholder Proposal - to Seek Shareholder Approval of Certain Termination Pay Arrangements

Shareholder

Against

For

Stockholder Proposal - to Issue a Report on Board Oversight of Competition Practices

Shareholder

Against

For

Stockholder Proposal - to Issue an Annual Report on Political Spending

Shareholder

Abstain

Against

COLGATE-PALMOLIVE COMPANY

Security

194162103

Meeting Type

Annual

Ticker Symbol

Meeting Date

06-May-2022

ISIN

US1941621039

Agenda

935571338 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: John P. Bilbrey

Management

For

1b.

Election of Director: John T. Cahill

Management

For

1c.

Election of Director: Lisa M. Edwards

Management

For

1d.

Election of Director: C. Martin Harris

Management

For

1e.

Election of Director: Martina Hund-Mejean

Management

For

1f.

Election of Director: Kimberly A. Nelson

Management

For

1g.

Election of Director: Lorrie M. Norrington

Management

For

1h.

Election of Director: Michael B. Polk

Management

For

1i.

Election of Director: Stephen I. Sadove

Management

For

1j.

Election of Director: Noel R. Wallace

Management

For

Ratify selection of PricewaterhouseCoopers LLP as Colgate’s independent registered public accounting firm.

Management

For

Advisory vote on executive compensation.

Management

For

Stockholder proposal regarding shareholder ratification of termination pay.

Shareholder

Against

For

Stockholder proposal regarding charitable donation disclosure.

Shareholder

Abstain

Against

TENET HEALTHCARE CORPORATION

Security

88033G407

Meeting Type

Annual

Ticker Symbol

THC

Meeting Date

06-May-2022

ISIN

US88033G4073

Agenda

935571453 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Ronald A. Rittenmeyer

Management

For

1B.

Election of Director: J. Robert Kerrey

Management

For

1C.

Election of Director: James L. Bierman

Management

For

1D.

Election of Director: Richard W. Fisher

Management

For

1E.

Election of Director: Meghan M. FitzGerald

Management

For

1F.

Election of Director: Cecil D. Haney

Management

For

1G.

Election of Director: Christopher S. Lynch

Management

For

1H.

Election of Director: Richard J. Mark

Management

For

1I.

Election of Director: Tammy Romo

Management

For

1J.

Election of Director: Saumya Sutaria

Management

For

1K.

Election of Director: Nadja Y. West

Management

For

To vote to approve, on an advisory basis, the Company’s executive compensation.

Management

For

To vote to approve the First Amendment to the Tenet Healthcare 2019 Stock Incentive Plan.

Management

For

To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2022.

Management

For

TACTILE SYSTEMS TECHNOLOGY, INC.

Security

87357P100

Meeting Type

Annual

Ticker Symbol

TCMD

Meeting Date

09-May-2022

ISIN

US87357P1003

Agenda

935576679 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Valerie Asbury

For

Bill Burke

For

Sheri Dodd

For

Raymond Huggenberger

For

Deepti Jain

For

Daniel Reuvers

For

Brent Shafer

For

Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

Approve, on an advisory basis, the 2021 compensation of our named executive officers.

Management

For

DANAHER CORPORATION

Security

235851102

Meeting Type

Annual

Ticker Symbol

DHR

Meeting Date

10-May-2022

ISIN

US2358511028

Agenda

935575057 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Rainer M. Blair

Management

For

1B.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Linda Filler

Management

For

1C.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Teri List

Management

For

1D.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Walter G. Lohr, Jr.

Management

For

1E.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH

Management

For

1F.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Mitchell P. Rales

Management

For

1G.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Steven M. Rales

Management

For

1H.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL

Management

For

1I.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: A. Shane Sanders

Management

For

1J.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: John T. Schwieters

Management

For

1K.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Alan G. Spoon

Management

For

1L.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D

Management

For

1M.

Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Elias A. Zerhouni, MD

Management

For

To ratify the selection of Ernst & Young LLP as Danaher’s independent registered public accounting firm for the year ending December 31, 2022.

Management

For

To approve on an advisory basis the Company’s named executive officer compensation.

Management

For

To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%.

Shareholder

Against

For

CHARLES RIVER LABORATORIES INTL., INC.

Security

159864107

Meeting Type

Annual

Ticker Symbol

CRL

Meeting Date

10-May-2022

ISIN

US1598641074

Agenda

935585464 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: James C. Foster

Management

For

1B.

Election of Director: Nancy C. Andrews

Management

For

1C.

Election of Director: Robert Bertolini

Management

For

1D.

Election of Director: Deborah T. Kochevar

Management

For

1E.

Election of Director: George Llado, Sr.

Management

For

1F.

Election of Director: Martin W. MacKay

Management

For

1G.

Election of Director: George E. Massaro

Management

For

1H.

Election of Director: C. Richard Reese

Management

For

1I.

Election of Director: Richard F. Wallman

Management

For

1J.

Election of Director: Virginia M. Wilson

Management

For

Advisory approval of 2021 Executive Compensation

Management

For

Ratification of PricewaterhouseCoopers LLC as independent registered accounting public firm for 2022

Management

For

CVS HEALTH CORPORATION

Security

126650100

Meeting Type

Annual

Ticker Symbol

CVS

Meeting Date

11-May-2022

ISIN

US1266501006

Agenda

935576972 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Fernando Aguirre

Management

For

1B.

Election of Director: C. David Brown II

Management

For

1C.

Election of Director: Alecia A. DeCoudreaux

Management

For

1D.

Election of Director: Nancy-Ann M. DeParle

Management

For

1E.

Election of Director: Roger N. Farah

Management

For

1F.

Election of Director: Anne M. Finucane

Management

For

1G.

Election of Director: Edward J. Ludwig

Management

For

1H.

Election of Director: Karen S. Lynch

Management

For

1I.

Election of Director: Jean-Pierre Millon

Management

For

1J.

Election of Director: Mary L. Schapiro

Management

For

1K.

Election of Director: William C. Weldon

Management

For

Ratification of the appointment of our independent registered public accounting firm for 2022.

Management

For

Say on Pay, a proposal to approve, on an advisory basis, the Company’s executive compensation.

Management

For

Stockholder proposal for reducing our ownership threshold to request a special stockholder meeting.

Shareholder

Against

For

Stockholder proposal regarding our independent Board Chair.

Shareholder

Against

For

Stockholder proposal on civil rights and non- discrimination audit focused on “non-diverse” employees.

Shareholder

Abstain

Against

Stockholder proposal requesting paid sick leave for all employees.

Shareholder

Abstain

Against

Stockholder proposal regarding a report on the public health costs of our food business to diversified portfolios.

Shareholder

Abstain

Against

LABORATORY CORP. OF AMERICA HOLDINGS

Security

50540R409

Meeting Type

Annual

Ticker Symbol

Meeting Date

11-May-2022

ISIN

US50540R4092

Agenda

935577479 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Kerrii B. Anderson

Management

For

1B.

Election of Director: Jean-Luc Bélingard

Management

For

1C.

Election of Director: Jeffrey A. Davis

Management

For

1D.

Election of Director: D. Gary Gilliland, M.D., Ph.D.

Management

For

1E.

Election of Director: Garheng Kong, M.D., Ph.D.

Management

For

1F.

Election of Director: Peter M. Neupert

Management

For

1G.

Election of Director: Richelle P. Parham

Management

For

1H.

Election of Director: Adam H. Schechter

Management

For

1I.

Election of Director: Kathryn E. Wengel

Management

For

1J.

Election of Director: R. Sanders Williams, M.D.

Management

For

To approve, by non-binding vote, executive compensation.

Management

For

Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings’ independent registered public accounting firm for the year ending December 31, 2022.

Management

For

Shareholder proposal seeking an amendment to our governing documents relating to procedural requirements in connection with shareholders’ rights to call a special meeting.

Shareholder

Against

For

NUVASIVE, INC.

Security

670704105

Meeting Type

Annual

Ticker Symbol

NUVA

Meeting Date

11-May-2022

ISIN

US6707041058

Agenda

935580832 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Class III Director: Robert F. Friel

Management

For

1.2

Election of Class III Director: Daniel J. Wolterman

Management

For

Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2021.

Management

For

AVANTOR, INC.

Security

05352A100

Meeting Type

Annual

Ticker Symbol

AVTR

Meeting Date

12-May-2022

ISIN

US05352A1007

Agenda

935575463 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Juan Andres

Management

For

1B.

Election of Director: John Carethers

Management

For

1C.

Election of Director: Matthew Holt

Management

For

1D.

Election of Director: Lan Kang

Management

For

1E.

Election of Director: Joseph Massaro

Management

For

1F.

Election of Director: Mala Murthy

Management

For

1G.

Election of Director: Jonathan Peacock

Management

For

1H.

Election of Director: Michael Severino

Management

For

1I.

Election of Director: Christi Shaw

Management

For

1J.

Election of Director: Michael Stubblefield

Management

For

1K.

Election of Director: Gregory Summe

Management

For

Ratification of the Appointment of Deloitte & Touche LLP as the Company’s independent registered accounting firm for 2022.

Management

For

Approve, on an Advisory Basis, Named Executive Officer Compensation.

Management

For

ZIMMER BIOMET HOLDINGS, INC.

Security

98956P102

Meeting Type

Annual

Ticker Symbol

ZBH

Meeting Date

13-May-2022

ISIN

US98956P1021

Agenda

935568139 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Christopher B. Begley

Management

For

1B.

Election of Director: Betsy J. Bernard

Management

For

1C.

Election of Director: Michael J. Farrell

Management

For

1D.

Election of Director: Robert A. Hagemann

Management

For

1E.

Election of Director: Bryan C. Hanson

Management

For

1F.

Election of Director: Arthur J. Higgins

Management

For

1G.

Election of Director: Maria Teresa Hilado

Management

For

1H.

Election of Director: Syed Jafry

Management

For

1I.

Election of Director: Sreelakshmi Kolli

Management

For

1J.

Election of Director: Michael W. Michelson

Management

For

Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022.

Management

For

Approve, on a non-binding advisory basis, named executive officer compensation (“Say on Pay”).

Management

For

CHEMED CORPORATION

Security

16359R103

Meeting Type

Annual

Ticker Symbol

CHE

Meeting Date

16-May-2022

ISIN

US16359R1032

Agenda

935607412 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Kevin J. McNamara

Management

For

1b.

Election of Director: Ron DeLyons

Management

For

1c.

Election of Director: Joel F. Gemunder

Management

For

1d.

Election of Director: Patrick P. Grace

Management

For

1e.

Election of Director: Christopher J. Heaney

Management

For

1f.

Election of Director: Thomas C. Hutton

Management

For

1g.

Election of Director: Andrea R. Lindell

Management

For

1h.

Election of Director: Thomas P. Rice

Management

For

1i.

Election of Director: Donald E. Saunders

Management

For

1j.

Election of Director: George J. Walsh III

Management

For

Approval and Adoption of the 2022 Stock Icentive Plan.

Management

Against

Ratification of Audit Committee’s selection of PricewaterhouseCoopers LLP as independent accountants for 2022.

Management

For

Advisory vote to approve executive compensation.

Management

For

QUIDEL CORPORATION

Security

74838J101

Meeting Type

Special

Ticker Symbol

QDEL

Meeting Date

16-May-2022

ISIN

US74838J1016

Agenda

935618009 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To approve and adopt the Business Combination Agreement (the “BCA”), dated December 22, 2021, by and among Quidel Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc, Coronado Topco, Inc. (“Topco”), Orca Holdco, Inc. (“U.S. Holdco Sub”) and Laguna Merger Sub, Inc., each wholly owned subsidiaries of Topco, and Orca Holdco 2, Inc., a wholly owned subsidiary of U.S. Holdco Sub, including the Quidel Merger (as defined in the joint proxy statement/prospectus) and the transactions contemplated thereby (the “Merger Proposal”)

Management

For

To approve, on a non-binding, advisory basis, certain compensation arrangements for Quidel’s named executive officers in connection with the BCA

Management

For

To approve any motion to adjourn the Special Meeting to another time or place, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal

Management

For

DIRECTOR

Management

Douglas C. Bryant

For

Kenneth F. Buechler

For

Edward L. Michael

For

Mary Lake Polan

For

Ann D. Rhoads

For

Matthew W. Strobeck

For

Kenneth J. Widder

For

Joseph D. Wilkins Jr.

For

To approve, on an advisory basis, the compensation of Quidel’s named executive officers

Management

For

To ratify the selection of Ernst & Young LLP as Quidel’s independent registered public accounting firm for the fiscal year ending December 31, 2022

Management

For

To approve an amendment and restatement of Quidel’s 2018 Equity Incentive Plan (the “2018 Plan”) to increase the number of shares of Quidel common stock available under the 2018 Plan

Management

For

To approve an amendment and restatement of Quidel’s 1983 Employee Stock Purchase Plan (the “1983 ESPP”) to increase the number of shares of Quidel common stock available under the 1983 ESPP

Management

For

ICU MEDICAL, INC.

Security

44930G107

Meeting Type

Annual

Ticker Symbol

ICUI

Meeting Date

17-May-2022

ISIN

US44930G1076

Agenda

935577126 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Vivek Jain

For

George A. Lopez, M.D.

For

David C. Greenberg

For

Elisha W. Finney

For

David F. Hoffmeister

For

Donald M. Abbey

For

Laurie Hernandez

For

Kolleen T. Kennedy

For

William Seeger

For

To ratify the selection of Deloitte & Touche LLP as auditors for the Company for the year ending December 31, 2022.

Management

For

To approve named executive officer compensation on an advisory basis.

Management

For

AMGEN INC.

Security

031162100

Meeting Type

Annual

Ticker Symbol

AMGN

Meeting Date

17-May-2022

ISIN

US0311621009

Agenda

935580729 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a term of expiring at the 2023 annual meeting: Dr. Wanda M. Austin

Management

For

1B.

Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Bradway

Management

For

1C.

Election of Director for a term of expiring at the 2023 annual meeting: Dr. Brian J. Druker

Management

For

1D.

Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Eckert

Management

For

1E.

Election of Director for a term of expiring at the 2023 annual meeting: Mr. Greg C. Garland

Management

For

1F.

Election of Director for a term of expiring at the 2023 annual meeting: Mr. Charles M. Holley, Jr.

Management

For

1G.

Election of Director for a term of expiring at the 2023 annual meeting: Dr. S. Omar Ishrak

Management

For

1H.

Election of Director for a term of expiring at the 2023 annual meeting: Dr. Tyler Jacks

Management

For

1I.

Election of Director for a term of expiring at the 2023 annual meeting: Ms. Ellen J. Kullman

Management

For

1J.

Election of Director for a term of expiring at the 2023 annual meeting: Ms. Amy E. Miles

Management

For

1K.

Election of Director for a term of expiring at the 2023 annual meeting: Dr. Ronald D. Sugar

Management

For

1L.

Election of Director for a term of expiring at the 2023 annual meeting: Dr. R. Sanders Williams

Management

For

Advisory vote to approve our executive compensation.

Management

For

To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2022.

Management

For

PERSONALIS, INC.

Security

71535D106

Meeting Type

Annual

Ticker Symbol

PSNL

Meeting Date

17-May-2022

ISIN

US71535D1063

Agenda

935589169 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: A. Blaine Bowman

Management

For

1.2

Election of Director: Karin Eastham

Management

For

Ratification of the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.

Management

For

Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers, as disclosed in the proxy statement accompanying this notice.

Management

For

Indication, on a non-binding, advisory basis, of the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.

Management

3 Years

For

ORASURE TECHNOLOGIES, INC.

Security

68554V108

Meeting Type

Annual

Ticker Symbol

OSUR

Meeting Date

17-May-2022

ISIN

US68554V1089

Agenda

935593942 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

ELECTION OF Class I DIRECTOR (Expiring 2025): Eamonn P. Hobbs

Management

For

1B.

ELECTION OF Class I DIRECTOR (Expiring 2025): David J. Shulkin, M.D.

Management

For

Ratification of Appointment of KPMG LLP as the Independent Registered Public Accounting Firm for Fiscal Year 2022.

Management

For

Advisory (Non-Binding) Vote to Approve Executive Compensation.

Management

For

Approval of Amendment and Restatement of the Company’s Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder.

Management

Against

INFUSYSTEM HOLDINGS, INC.

Security

45685K102

Meeting Type

Annual

Ticker Symbol

INFU

Meeting Date

17-May-2022

ISIN

US45685K1025

Agenda

935597104 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Ralph Boyd

For

Richard Dilorio

For

Paul Gendron

For

Carrie Lachance

For

Gregg Lehman

For

Christopher Sansone

For

Scott Shuda

For

Approval, on an advisory basis, of the Company’s executive compensation.

Management

For

Ratification of the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

AURINIA PHARMACEUTICALS INC.

Security

05156V102

Meeting Type

Annual

Ticker Symbol

AUPH

Meeting Date

17-May-2022

ISIN

CA05156V1022

Agenda

935624456 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Dr. George M. Milne

For

Mr. Peter Greenleaf

For

Dr. David R.W. Jayne

For

Mr. Joseph P. Hagan

For

Dr. Daniel G. Billen

For

Mr. R. H. MacKay-Dunn

For

Ms. Jill Leversage

For

Mr. Timothy P. Walbert

For

Dr. Brinda Balakrishnan

For

Appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the 2023 annual general meeting of shareholders or until a successor is appointed.

Management

For

To approve, on a non-binding advisory basis, a “say on pay” resolution regarding the Company’s executive compensation set forth in the Company’s Proxy Statement/Circular.

Management

For

ANTHEM, INC.

Security

036752103

Meeting Type

Annual

Ticker Symbol

ANTM

Meeting Date

18-May-2022

ISIN

US0367521038

Agenda

935576720 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Susan D. DeVore

Management

For

1.2

Election of Director: Bahija Jallal

Management

For

1.3

Election of Director: Ryan M. Schneider

Management

For

1.4

Election of Director: Elizabeth E. Tallett

Management

For

Advisory vote to approve the compensation of our named executive officers.

Management

For

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022.

Management

For

To approve an amendment to our Articles of Incorporation to change our name to Elevance Health, Inc.

Management

For

Shareholder proposal to prohibit political funding.

Shareholder

Against

For

Shareholder proposal requesting a racial impact audit and report.

Shareholder

Abstain

Against

OPTION CARE HEALTH, INC.

Security

68404L201

Meeting Type

Annual

Ticker Symbol

OPCH

Meeting Date

18-May-2022

ISIN

US68404L2016

Agenda

935578899 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Anita M. Allemand

For

John J. Arlotta

For

Elizabeth Q. Betten

For

Elizabeth D. Bierbower

For

Natasha Deckmann

For

Aaron Friedman

For

David W. Golding

For

Harry M. J. Kraemer Jr.

For

R. Carter Pate

For

John C. Rademacher

For

Nitin Sahney

For

Timothy Sullivan

For

Mark Vainisi

For

To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

To approve, on a non-binding advisory basis, our executive compensation.

Management

For

ELANCO ANIMAL HEALTH INCORPORATED

Security

28414H103

Meeting Type

Annual

Ticker Symbol

ELAN

Meeting Date

18-May-2022

ISIN

US28414H1032

Agenda

935584119 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Kapila K. Anand

Management

For

1b.

Election of Director: John P. Bilbrey

Management

For

1c.

Election of Director: Scott D. Ferguson

Management

For

1d.

Election of Director: Paul Herendeen

Management

For

1e.

Election of Director: Lawrence E. Kurzius

Management

For

Ratification of the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for 2022.

Management

For

Advisory vote on the approval of executive compensation.

Management

For

Approval of the Elanco Animal Health Incorporated Employee Stock Purchase Plan.

Management

For

Approval of amendments to the company’s Amended and Restated Articles of Incorporation to eliminate supermajority voting requirements.

Management

For

Approval of amendments to the company’s Amended and Restated Articles of Incorporation to eliminate legacy parent provisions.

Management

For

THERMO FISHER SCIENTIFIC INC.

Security

883556102

Meeting Type

Annual

Ticker Symbol

TMO

Meeting Date

18-May-2022

ISIN

US8835561023

Agenda

935585058 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of director: Marc N. Casper

Management

For

1B.

Election of director: Nelson J. Chai

Management

For

1C.

Election of director: Ruby R. Chandy

Management

For

1D.

Election of director: C. Martin Harris

Management

For

1E.

Election of director: Tyler Jacks

Management

For

1F.

Election of director: R. Alexandra Keith

Management

For

1G.

Election of director: Jim P. Manzi

Management

For

1H.

Election of director: James C. Mullen

Management

For

1I.

Election of director: Lars R. Sorensen

Management

For

1J.

Election of director: Debora L. Spar

Management

For

1K.

Election of director: Scott M. Sperling

Management

For

1L.

Election of director: Dion J. Weisler

Management

For

An advisory vote to approve named executive officer compensation.

Management

For

Ratification of the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent auditors for 2022.

Management

For

MONDELEZ INTERNATIONAL, INC.

Security

609207105

Meeting Type

Annual

Ticker Symbol

MDLZ

Meeting Date

18-May-2022

ISIN

US6092071058

Agenda

935587379 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Lewis W.K. Booth

Management

For

1B.

Election of Director: Charles E. Bunch

Management

For

1C.

Election of Director: Ertharin Cousin

Management

For

1D.

Election of Director: Lois D. Juliber

Management

For

1E.

Election of Director: Jorge S. Mesquita

Management

For

1F.

Election of Director: Jane Hamilton Nielsen

Management

For

1G.

Election of Director: Christiana S. Shi

Management

For

1H.

Election of Director: Patrick T. Siewert

Management

For

1I.

Election of Director: Michael A. Todman

Management

For

1J.

Election of Director: Dirk Van de Put

Management

For

Advisory Vote to Approve Executive Compensation.

Management

For

Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accountants for Fiscal Year Ending December 31, 2022.

Management

For

Conduct and Publish Racial Equity Audit.

Shareholder

Abstain

Against

Require Independent Chair of the Board.

Shareholder

Against

For

VERTEX PHARMACEUTICALS INCORPORATED

Security

92532F100

Meeting Type

Annual

Ticker Symbol

VRTX

Meeting Date

18-May-2022

ISIN

US92532F1003

Agenda

935588042 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Sangeeta Bhatia

Management

For

1B.

Election of Director: Lloyd Carney

Management

For

1C.

Election of Director: Alan Garber

Management

For

1D.

Election of Director: Terrence Kearney

Management

For

1E.

Election of Director: Reshma Kewalramani

Management

For

1F.

Election of Director: Yuchun Lee

Management

For

1G.

Election of Director: Jeffrey Leiden

Management

For

1H.

Election of Director: Margaret McGlynn

Management

For

1I.

Election of Director: Diana McKenzie

Management

For

1J.

Election of Director: Bruce Sachs

Management

For

1K.

Election of Director: Suketu Upadhyay

Management

For

Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2022.

Management

For

Advisory vote to approve named executive office compensation.

Management

For

Approval of an amendment and restatement of our 2013 Stock and Option Plan to increase the number of shares authorized for issuance under this plan by 13.5 million shares.

Management

Against

HENRY SCHEIN, INC.

Security

806407102

Meeting Type

Annual

Ticker Symbol

HSIC

Meeting Date

18-May-2022

ISIN

US8064071025

Agenda

935592306 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Mohamad Ali

Management

For

1B.

Election of Director: Stanley M. Bergman

Management

For

1C.

Election of Director: James P. Breslawski

Management

For

1D.

Election of Director: Deborah Derby

Management

For

1E.

Election of Director: Joseph L. Herring

Management

For

1F.

Election of Director: Kurt P. Kuehn

Management

For

1G.

Election of Director: Philip A. Laskawy

Management

For

1H.

Election of Director: Anne H. Margulies

Management

For

1I.

Election of Director: Mark E. Mlotek

Management

For

1J.

Election of Director: Steven Paladino

Management

For

1K.

Election of Director: Carol Raphael

Management

For

1L.

Election of Director: E. Dianne Rekow, DDS, Ph.D.

Management

For

1M.

Election of Director: Scott Serota

Management

For

1N.

Election of Director: Bradley T. Sheares, Ph.D.

Management

For

1O.

Election of Director: Reed V. Tuckson, M.D., FACP

Management

For

Proposal to approve, by non-binding vote, the 2021 compensation paid to the Company’s Named Executive Officers.

Management

For

Proposal to ratify the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

INTEGER HOLDINGS CORPORATION

Security

45826H109

Meeting Type

Annual

Ticker Symbol

ITGR

Meeting Date

18-May-2022

ISIN

US45826H1095

Agenda

935592700 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a one-year term: Sheila Antrum

Management

For

1B.

Election of Director for a one-year term: Pamela G. Bailey

Management

For

1C.

Election of Director for a one-year term: Cheryl C. Capps

Management

For

1D.

Election of Director for a one-year term: Joseph W. Dziedzic

Management

For

1E.

Election of Director for a one-year term: James F. Hinrichs

Management

For

1F.

Election of Director for a one-year term: Jean Hobby

Management

For

1G.

Election of Director for a one-year term: Tyrone Jeffers

Management

For

1H.

Election of Director for a one-year term: M. Craig Maxwell

Management

For

1I.

Election of Director for a one-year term: Filippo Passerini

Management

For

1J.

Election of Director for a one-year term: Donald J. Spence

Management

For

1K.

Election of Director for a one-year term: William B. Summers, Jr

Management

For

To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2022.

Management

For

To approve, on an advisory basis, the compensation of our named executive officers.

Management

For

QUEST DIAGNOSTICS INCORPORATED

Security

74834L100

Meeting Type

Annual

Ticker Symbol

DGX

Meeting Date

18-May-2022

ISIN

US74834L1008

Agenda

935621107 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Tracey C. Doi

Management

For

1.2

Election of Director: Vicky B. Gregg

Management

For

1.3

Election of Director: Wright L. Lassiter III

Management

For

1.4

Election of Director: Timothy L. Main

Management

For

1.5

Election of Director: Denise M. Morrison

Management

For

1.6

Election of Director: Gary M. Pfeiffer

Management

For

1.7

Election of Director: Timothy M. Ring

Management

For

1.8

Election of Director: Stephen H. Rusckowski

Management

For

1.9

Election of Director: Gail R. Wilensky

Management

For

An advisory resolution to approve the executive officer compensation disclosed in the Company’s 2022 proxy statement

Management

For

Ratification of the appointment of our independent registered public accounting firm for 2022

Management

For

To adopt an amendment to the Company’s Certificate of Incorporation to allow stockholders to act by non- unanimous written consent

Management

For

To adopt an amendment to the Company’s Certificate of Incorporation to permit stockholders holding 15% or more of the Company’s common stock to request that the Company call a special meeting of stockholders

Management

For

Stockholder proposal regarding the right to call a special meeting of stockholders

Shareholder

Against

For

ZOETIS INC.

Security

98978V103

Meeting Type

Annual

Ticker Symbol

ZTS

Meeting Date

19-May-2022

ISIN

US98978V1035

Agenda

935591176 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Paul M. Bisaro

Management

For

1B.

Election of Director: Frank A. D’Amelio

Management

For

1C.

Election of Director: Michael B. McCallister

Management

For

Advisory vote to approve our executive compensation.

Management

For

Approval of an Amendment and Restatement of our 2013 Equity and Incentive Plan.

Management

For

Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2022.

Management

For

Approval of an amendment to our Restated Certificate of Incorporation to eliminate supermajority voting provisions and certain provisions related to Pfizer Inc.

Management

For

Approval of an amendment to our Restated Certificate of Incorporation to declassify the Board of Directors.

Management

For

MEDPACE HOLDINGS, INC.

Security

58506Q109

Meeting Type

Annual

Ticker Symbol

MEDP

Meeting Date

20-May-2022

ISIN

US58506Q1094

Agenda

935589791 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

August J. Troendle

For

Ashley M. Keating

For

To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2022 Annual Meeting.

Management

For

MERCK & CO., INC.

Security

58933Y105

Meeting Type

Annual

Ticker Symbol

MRK

Meeting Date

24-May-2022

ISIN

US58933Y1055

Agenda

935591570 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Douglas M. Baker, Jr.

Management

For

1B.

Election of Director: Mary Ellen Coe

Management

For

1C.

Election of Director: Pamela J. Craig

Management

For

1D.

Election of Director: Robert M. Davis

Management

For

1E.

Election of Director: Kenneth C. Frazier

Management

For

1F.

Election of Director: Thomas H. Glocer

Management

For

1G.

Election of Director: Risa J. Lavizzo-Mourey, M.D.

Management

For

1H.

Election of Director: Stephen L. Mayo, Ph.D.

Management

For

1I.

Election of Director: Paul B. Rothman, M.D.

Management

For

1J.

Election of Director: Patricia F. Russo

Management

For

1K.

Election of Director: Christine E. Seidman, M.D.

Management

For

1L.

Election of Director: Inge G. Thulin

Management

For

1M.

Election of Director: Kathy J. Warden

Management

For

1N.

Election of Director: Peter C. Wendell

Management

For

Non-binding advisory vote to approve the compensation of our named executive officers.

Management

For

Ratification of the appointment of the Company’s independent registered public accounting firm for 2022.

Management

For

Shareholder proposal regarding an independent board chairman.

Shareholder

Against

For

Shareholder proposal regarding access to COVID-19 products.

Shareholder

Abstain

Against

Shareholder proposal regarding lobbying expenditure disclosure.

Shareholder

Abstain

Against

WATERS CORPORATION

Security

941848103

Meeting Type

Annual

Ticker Symbol

WAT

Meeting Date

24-May-2022

ISIN

US9418481035

Agenda

935598497 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Dr. Udit Batra, Ph.D.

Management

For

1.2

Election of Director: Linda Baddour

Management

For

1.3

Election of Director: Edward Conard

Management

For

1.4

Election of Director: Dr. Pearl S. Huang, Ph.D.

Management

For

1.5

Election of Director: Wei Jiang

Management

For

1.6

Election of Director: Christopher A. Kuebler

Management

For

1.7

Election of Director: Dr. Flemming Ornskov, M.D., M.P.H.

Management

For

1.8

Election of Director: Thomas P. Salice

Management

For

To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve, by non-binding vote, executive compensation.

Management

For

INTRICON CORPORATION

Security

46121H109

Meeting Type

Special

Ticker Symbol

IIN

Meeting Date

24-May-2022

ISIN

US46121H1095

Agenda

935639964 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

To (a) approve and adopt the Agreement and Plan of Merger, dated 2/27/22 (as amended, the “Merger Agreement”), by and among Intricon (“Intricon”), IIN Holding Company LLC (“Parent”), and IC Merger Sub Inc., a wholly owned subsidiary of Parent (“Merger Sub”), and (b) pursuant to the Merger Agreement, approve the merger of Merger Sub with and into Intricon, as a result of which the separate corporate existence of Merger Sub will cease, with Intricon continuing as the surviving corporation (the “Merger”) and a wholly owned subsidiary of Parent.

Management

For

To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intricon Corporation’s named executive officers that is based on or otherwise is related to the Merger Agreement and the transactions contemplated by the Merger Agreement.

Management

For

To approve any proposal to adjourn the Special Meeting from time to time, if necessary or appropriate as determined in the discretion of the Board of Directors of Intricon Corporation to solicit additional proxies if there are insufficient votes to approve and adopt the Merger Agreement and approve the Merger at the time of the Special Meeting.

Management

For

SPROUTS FARMERS MARKET, INC.

Security

85208M102

Meeting Type

Annual

Ticker Symbol

SFM

Meeting Date

25-May-2022

ISIN

US85208M1027

Agenda

935586961 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Kristen E. Blum

For

Jack L. Sinclair

For

To vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for fiscal 2021 (“say-on-pay”).

Management

For

To approve the Sprouts Farmers Market, Inc. 2022 Omnibus Incentive Compensation Plan.

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023.

Management

For

AXOGEN, INC.

Security

05463X106

Meeting Type

Annual

Ticker Symbol

AXGN

Meeting Date

25-May-2022

ISIN

US05463X1063

Agenda

935596962 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Karen Zaderej

For

Gregory Freitag

For

Dr. Mark Gold

For

John H. Johnson

For

Alan M. Levine

For

Guido Neels

For

Paul Thomas

For

Amy Wendell

For

To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s Proxy Statement.

Management

For

To approve the Axogen, Inc. Second Amended and Restated 2019 Long-Term Incentive Plan.

Management

Against

To approve an amendment to the Axogen, Inc. Amended and Restated Bylaws.

Management

Against

NATERA, INC.

Security

632307104

Meeting Type

Annual

Ticker Symbol

NTRA

Meeting Date

25-May-2022

ISIN

US6323071042

Agenda

935603755 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Roy Baynes

For

James Healy

For

Gail Marcus

For

To ratify the appointment of Ernst & Young LLP as Natera, Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.’s named executive officers as disclosed in the proxy statement.

Management

For

DENTSPLY SIRONA INC.

Security

24906P109

Meeting Type

Annual

Ticker Symbol

XRAY

Meeting Date

25-May-2022

ISIN

US24906P1093

Agenda

935603870 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Eric K. Brandt

Management

For

1B.

Election of Director: Donald M. Casey Jr.

Management

Abstain

Against

1C.

Election of Director: Willie A. Deese

Management

For

1D.

Election of Director: John P. Groetelaars

Management

For

1E.

Election of Director: Betsy D. Holden

Management

For

1F.

Election of Director: Clyde R. Hosein

Management

For

1G.

Election of Director: Harry M. Kraemer Jr.

Management

For

1H.

Election of Director: Gregory T. Lucier

Management

For

1I.

Election of Director: Leslie F. Varon

Management

For

1J.

Election of Director: Janet S. Vergis

Management

For

1K.

Election of Director: Dorothea Wenzel

Management

For

Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for 2022.

Management

For

Approval, by non-binding vote, of the Company’s executive compensation.

Management

For

Approval of the Amendment to the Fifth Amended and Restated By- Laws to Designate the Exclusive Forum for the Adjudication of Certain Legal Matters.

Management

For

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Security

69404D108

Meeting Type

Annual

Ticker Symbol

PACB

Meeting Date

25-May-2022

ISIN

US69404D1081

Agenda

935605014 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Class III Director: David Botstein, Ph.D.

Management

For

1.2

Election of Class III Director: William Ericson

Management

For

1.3

Election of Class III Director: Kathy Ordoñez

Management

For

Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Approval of an amendment of our 2020 Equity Incentive Plan to increase the number of shares reserved thereunder.

Management

Against

FLOWERS FOODS, INC.

Security

343498101

Meeting Type

Annual

Ticker Symbol

FLO

Meeting Date

26-May-2022

ISIN

US3434981011

Agenda

935596594 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director to serve for a term of one year: George E. Deese

Management

For

1B.

Election of Director to serve for a term of one year: Edward J. Casey, Jr.

Management

For

1C.

Election of Director to serve for a term of one year: Thomas C. Chubb, III

Management

For

1D.

Election of Director to serve for a term of one year: Rhonda Gass

Management

For

1E.

Election of Director to serve for a term of one year: Benjamin H. Griswold, IV

Management

For

1F.

Election of Director to serve for a term of one year: Margaret G. Lewis

Management

For

1G.

Election of Director to serve for a term of one year: W. Jameson McFadden

Management

For

1H.

Election of Director to serve for a term of one year: A. Ryals McMullian

Management

For

1I.

Election of Director to serve for a term of one year: James T. Spear

Management

For

1J.

Election of Director to serve for a term of one year: Melvin T. Stith, Ph.D.

Management

For

1K.

Election of Director to serve for a term of one year: Terry S. Thomas

Management

For

1L.

Election of Director to serve for a term of one year: C. Martin Wood III

Management

For

To approve by advisory vote the compensation of the company’s named executive officers.

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Flowers Foods, Inc. for the fiscal year ending December 31, 2022.

Management

For

To consider a shareholder proposal regarding political contribution disclosure, if properly presented at the annual meeting.

Shareholder

Abstain

Against

STERICYCLE, INC.

Security

858912108

Meeting Type

Annual

Ticker Symbol

SRCL

Meeting Date

26-May-2022

ISIN

US8589121081

Agenda

935598411 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Robert S. Murley

Management

For

1B.

Election of Director: Cindy J. Miller

Management

For

1C.

Election of Director: Brian P. Anderson

Management

For

1D.

Election of Director: Lynn D. Bleil

Management

For

1E.

Election of Director: Thomas F. Chen

Management

For

1F.

Election of Director: J. Joel Hackney, Jr.

Management

For

1G.

Election of Director: Stephen C. Hooley

Management

For

1H.

Election of Director: Kay G. Priestly

Management

For

1I.

Election of Director: James L. Welch

Management

For

Advisory vote to approve executive compensation

Management

For

Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2022

Management

For

Stockholder proposal entitled Special Shareholder Meeting Improvement

Shareholder

Against

For

Stockholder proposal related to a civil rights audit

Shareholder

Abstain

Against

TELADOC HEALTH, INC.

Security

87918A105

Meeting Type

Annual

Ticker Symbol

TDOC

Meeting Date

26-May-2022

ISIN

US87918A1051

Agenda

935600862 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director for a term of one year: Karen L. Daniel

Management

For

1B.

Election of Director for a term of one year: Sandra L. Fenwick

Management

For

1C.

Election of Director for a term of one year: William H. Frist, M.D.

Management

For

1D.

Election of Director for a term of one year: Jason Gorevic

Management

For

1E.

Election of Director for a term of one year: Catherine A. Jacobson

Management

For

1F.

Election of Director for a term of one year: Thomas G. McKinley

Management

For

1G.

Election of Director for a term of one year: Kenneth H. Paulus

Management

For

1H.

Election of Director for a term of one year: David L. Shedlarz

Management

For

1I.

Election of Director for a term of one year: Mark Douglas Smith, M.D., MBA

Management

For

1J.

Election of Director for a term of one year: David B. Snow, Jr.

Management

For

Approve, on an advisory basis, the compensation of Teladoc Health’s named executive officers.

Management

For

Ratify the appointment of Ernst & Young LLP as Teladoc Health’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Approve an amendment to Teladoc Health’s Certificate of Incorporation to permit holders of at least 15% net long ownership in voting power of Teladoc Health’s outstanding capital stock to call special meetings.

Management

For

NEURONETICS, INC.

Security

64131A105

Meeting Type

Annual

Ticker Symbol

STIM

Meeting Date

26-May-2022

ISIN

US64131A1051

Agenda

935601218 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

John Bakewell

For

Robert Cascella

For

Sheryl Conley

For

Wilfred Jaeger

For

Glenn Muir

For

Megan Rosengarten

For

Bruce Shook

For

Keith J. Sullivan

For

Ratification of the selection of KPMG LLP as our independent registered public accounting firm.

Management

For

ILLUMINA, INC.

Security

452327109

Meeting Type

Annual

Ticker Symbol

ILMN

Meeting Date

26-May-2022

ISIN

US4523271090

Agenda

935603921 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Frances Arnold, Ph.D.

Management

For

1B.

Election of Director: Francis A. deSouza

Management

For

1C.

Election of Director: Caroline D. Dorsa

Management

For

1D.

Election of Director: Robert S. Epstein, M.D.

Management

For

1E.

Election of Director: Scott Gottlieb, M.D.

Management

For

1F.

Election of Director: Gary S. Guthart, Ph.D.

Management

For

1G.

Election of Director: Philip W. Schiller

Management

For

1H.

Election of Director: Susan E. Siegel

Management

For

1I.

Election of Director: John W. Thompson

Management

For

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023.

Management

For

To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.

Management

For

To approve, on an advisory basis, a stockholder proposal regarding the right of stockholders to call special meetings.

Shareholder

Against

For

To approve an amendment to our Amended and Restated Certificate of Incorporation to permit stockholders to call special meetings.

Management

For

BERKELEY LIGHTS, INC.

Security

084310101

Meeting Type

Annual

Ticker Symbol

BLI

Meeting Date

26-May-2022

ISIN

US0843101017

Agenda

935623353 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Jessica Hopfield, Ph.D.

For

Igor Khandros, Ph.D.

For

Michael Moritz

For

Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;

Management

For

An advisory vote on the frequency of future advisory votes to approve the compensation paid to our named executive officers; and

Management

1 Year

For

IRHYTHM TECHNOLOGIES, INC.

Security

450056106

Meeting Type

Annual

Ticker Symbol

IRTC

Meeting Date

26-May-2022

ISIN

US4500561067

Agenda

935638431 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

C. Noel Bairey Merz MD*

For

Mark J. Rubash*

For

Renee Budig*

For

Abhijit Y. Talwalkar#

For

Bruce G. Bodaken#

For

Ralph Synderman, M.D.#

For

To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.

Management

For

Advisory vote to approve Named Executive Officer Compensation.

Management

For

CARECLOUD, INC.

Security

14167R100

Meeting Type

Annual

Ticker Symbol

MTBC

Meeting Date

01-Jun-2022

ISIN

US14167R1005

Agenda

935610887 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

A. Hadi Chaudhry

For

John N. Daly

For

Mahmud Haq

For

Cameron P. Munter

For

To amend CareCloud, Inc.’s (the “Company”) certificate of incorporation to increase the Company’s authorized shares of common stock from twenty-nine million shares to thirty-five million shares.

Management

For

To amend the Company’s certificate of incorporation to increase the Company’s authorized shares of preferred stock from seven million shares to fifteen million shares.

Management

For

To amend the Company’s Amended and Restated Equity Incentive Plan (the “Equity Plan”) to increase the number of shares of the Company’s common stock issuable under the plan from 4,851,000 shares to 5,851,000 shares.

Management

Against

To amend the Company’s Equity Plan to add 200,000 shares of the Company’s Series B Preferred Stock issuable under the plan.

Management

For

NEOGENOMICS, INC.

Security

64049M209

Meeting Type

Annual

Ticker Symbol

NEO

Meeting Date

02-Jun-2022

ISIN

US64049M2098

Agenda

935603541 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Director: Lynn A. Tetrault

Management

For

1B.

Election of Director: Bruce K. Crowther

Management

For

1C.

Election of Director: David J. Daly

Management

For

1D.

Election of Director: Dr. Alison L. Hannah

Management

For

1E.

Election of Director: Stephen M. Kanovsky

Management

For

1F.

Election of Director: Michael A. Kelly

Management

For

1G.

Election of Director: Rachel A. Stahler

Management

For

Approval, on an advisory basis, of the Compensation Paid to the Company’s Named Executive Officers.

Management

For

Approval of the Third Amendment of the Amended and Restated Employee Stock Purchase Plan.

Management

For

Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm.

Management

For

GLOBUS MEDICAL, INC.

Security

379577208

Meeting Type

Annual

Ticker Symbol

GMED

Meeting Date

02-Jun-2022

ISIN

US3795772082

Agenda

935614291 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: David C. Paul

Management

For

1b.

Election of Director: Daniel T. Lemaitre

Management

For

1c.

Election of Director: Ann D. Rhoads

Management

For

The approval of the amendment to the 2021 Equity Incentive Plan.

Management

Against

To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.

Management

For

To approve, in an advisory vote, the compensation of the Company’s named executive officers (the Say-on-Pay Vote).

Management

For

GLAUKOS CORPORATION

Security

377322102

Meeting Type

Annual

Ticker Symbol

GKOS

Meeting Date

02-Jun-2022

ISIN

US3773221029

Agenda

935616889 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Mark J. Foley

For

David F. Hoffmeister

For

Gilbert H. Kliman, M.D.

For

Approval, on an advisory basis, of the compensation of the Company’s named executive officers.

Management

For

Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.

Management

For

SAREPTA THERAPEUTICS INC.

Security

803607100

Meeting Type

Annual

Ticker Symbol

SRPT

Meeting Date

02-Jun-2022

ISIN

US8036071004

Agenda

935634508 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Class I Director to hold office until the 2024 Annual meeting: Kathryn Boor, Ph.D.

Management

For

1.2

Election of Class I Director to hold office until the 2024 Annual meeting: Michael Chambers

Management

For

1.3

Election of Class I Director to hold office until the 2024 Annual meeting: Douglas S. Ingram

Management

For

1.4

Election of Class I Director to hold office until the 2024 Annual meeting: Hans Wigzell, M.D., Ph.D.

Management

For

To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.

Management

For

To approve an amendment to the Company’s 2018 Equity Incentive Plan (the “2018 Plan”) to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2018 Plan by 2,500,000 shares to 10,687,596 shares.

Management

Against

To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the current year ending December 31, 2022.

Management

For

SMILEDIRECTCLUB, INC.

Security

83192H106

Meeting Type

Annual

Ticker Symbol

SDC

Meeting Date

03-Jun-2022

ISIN

US83192H1068

Agenda

935618934 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Jordan Katzman

For

Steven Katzman

For

Ratification of Ernst & Young LLP as the company’s independent registered accounting firm for the fiscal year ending December 31, 2022.

Management

For

Advisory vote to approve the company’s named executive officer compensation.

Management

For

Advisory vote on the frequency of holding an advisory vote on the company’s named executive officer compensation.

Management

1 Year

For

INVITAE CORPORATION

Security

46185L103

Meeting Type

Annual

Ticker Symbol

NVTA

Meeting Date

06-Jun-2022

ISIN

US46185L1035

Agenda

935616550 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Class III Director: Eric Aguiar, M.D.

Management

For

1b.

Election of Class III Director: Sean E. George, Ph.D.

Management

For

Amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 400,000,000 shares to 600,000,000 shares.

Management

For

Approval of, on a non-binding advisory basis, the compensation paid by us to our named executive officers.

Management

For

Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

Stockholder proposal to elect each director annually, if properly presented at the annual meeting.

Shareholder

Against

For

UnitedHealth Group

Security

91324P102

Meeting Type

Annual

Ticker Symbol

UNH

Meeting Date

06-Jun-2022

ISIN

US91324P1021

Agenda

935618453 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Timothy P. Flynn

Management

For

1b.

Election of Director: Paul R. Garcia

Management

For

1c.

Election of Director: Stephen J. Hemsley

Management

For

1d.

Election of Director: Michele J. Hooper

Management

For

1e.

Election of Director: F. William McNabb III

Management

For

1f.

Election of Director: Valerie C. Montgomery Rice, M.D.

Management

For

1g.

Election of Director: John H. Noseworthy, M.D.

Management

For

1h.

Election of Director: Andrew Witty

Management

For

Advisory approval of the Company’s executive compensation.

Management

For

Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2022.

Management

For

If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay.

Shareholder

Against

For

If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal regarding political contributions congruency report.

Shareholder

Abstain

Against

ORTHOFIX MEDICAL INC.

Security

68752M108

Meeting Type

Annual

Ticker Symbol

OFIX

Meeting Date

06-Jun-2022

ISIN

US68752M1080

Agenda

935622945 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Wayne Burris

Management

For

1.2

Election of Director: Catherine M. Burzik

Management

For

1.3

Election of Director: Jason M. Hannon

Management

For

1.4

Election of Director: James F. Hinrichs

Management

For

1.5

Election of Director: Lilly Marks

Management

For

1.6

Election of Director: Michael E. Paolucci

Management

For

1.7

Election of Director: Jon C. Serbousek

Management

For

1.8

Election of Director: John E. Sicard

Management

For

1.9

Election of Director: Thomas A. West

Management

For

Advisory and non-binding resolution on the compensation of Orthofix Medical Inc.’s named executive officers.

Management

For

Approval of Amendment No. 3 to the Orthofix Medical Inc. Amended and Restated 2012 Long-Term Incentive Plan.

Management

Against

Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for Orthofix Medical Inc. and its subsidiaries for the fiscal year ending December 31, 2022.

Management

For

ORGANON & CO.

Security

68622V106

Meeting Type

Annual

Ticker Symbol

OGN

Meeting Date

07-Jun-2022

ISIN

US68622V1061

Agenda

935629177 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Class I Director: Robert Essner

Management

For

1b.

Election of Class I Director: Shelly Lazarus

Management

For

1c.

Election of Class I Director: Cynthia M. Patton

Management

For

1d.

Election of Class I Director: Grace Puma

Management

For

Approve, on a non-binding advisory basis, the compensation of Organon’s Named Executive Officers.

Management

For

Approve, on a non-binding advisory basis, the frequency of future votes to approve the compensation of Organon’s Named Executive Officers.

Management

1 Year

For

Ratify the appointment of PricewaterhouseCoopers LLP as Organon’s independent registered public accounting firm for 2022.

Management

For

ACADIA PHARMACEUTICALS INC.

Security

004225108

Meeting Type

Annual

Ticker Symbol

ACAD

Meeting Date

07-Jun-2022

ISIN

US0042251084

Agenda

935657796 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Laura A. Brege

For

Stephen R. Davis

For

Elizabeth A. Garofalo

For

To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 6,000,000 shares.

Management

Against

To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.

Management

For

To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

GERRESHEIMER AG

Security

D2852S109

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

08-Jun-2022

ISIN

DE000A0LD6E6

Agenda

715545868 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN.-IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY BE REJECTED.

Non-Voting

CMMT

FROM 10TH FEBRUARY, BROADRIDGE WILL CODE ALL AGENDAS FOR GERMAN MEETINGS IN-ENGLISH ONLY. IF YOU WISH TO SEE THE AGENDA IN GERMAN, THIS WILL BE MADE-AVAILABLE AS A LINK UNDER THE ‘MATERIAL URL’ DROPDOWN AT THE TOP OF THE-BALLOT. THE GERMAN AGENDAS FOR ANY EXISTING OR PAST MEETINGS WILL REMAIN IN-PLACE. FOR FURTHER INFORMATION, PLEASE CONTACT YOUR CLIENT SERVICE- REPRESENTATIVE.

Non-Voting

CMMT

ACCORDING TO GERMAN LAW, IN CASE OF SPECIFIC CONFLICTS OF INTEREST IN- CONNECTION WITH SPECIFIC ITEMS OF THE AGENDA FOR THE GENERAL MEETING YOU ARE- NOT ENTITLED TO EXERCISE YOUR VOTING RIGHTS. FURTHER, YOUR VOTING RIGHT MIGHT-BE EXCLUDED WHEN YOUR SHARE IN VOTING RIGHTS HAS REACHED CERTAIN THRESHOLDS-AND YOU HAVE NOT COMPLIED WITH ANY OF YOUR MANDATORY VOTING RIGHTS-NOTIFICATIONS PURSUANT TO THE GERMAN SECURITIES TRADING ACT (WPHG). FOR-QUESTIONS IN THIS REGARD PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE-FOR CLARIFICATION. IF YOU DO NOT HAVE ANY INDICATION REGARDING SUCH CONFLICT-OF INTEREST, OR ANOTHER EXCLUSION FROM VOTING, PLEASE SUBMIT YOUR VOTE AS- USUAL.

Non-Voting

CMMT

INFORMATION ON COUNTER PROPOSALS CAN BE FOUND DIRECTLY ON THE ISSUER’S-WEBSITE (PLEASE REFER TO THE MATERIAL URL SECTION OF THE APPLICATION). IF YOU-WISH TO ACT ON THESE ITEMS, YOU WILL NEED TO REQUEST A MEETING ATTEND AND-VOTE YOUR SHARES DIRECTLY AT THE COMPANY’S MEETING. COUNTER PROPOSALS CANNOT-BE REFLECTED ON THE BALLOT ON PROXYEDGE.

Non-Voting

CMMT

“INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE”

Non-Voting

RECEIVE FINANCIAL STATEMENTS AND STATUTORY REPORTS FOR SHORT FISCAL YEAR 2021

Non-Voting

APPROVE ALLOCATION OF INCOME AND DIVIDENDS OF EUR 1.25 PER SHARE

Management

No Action

APPROVE DISCHARGE OF MANAGEMENT BOARD FOR FISCAL YEAR 2021

Management

No Action

APPROVE DISCHARGE OF SUPERVISORY BOARD FOR FISCAL YEAR 2021

Management

No Action

RATIFY DELOITTE GMBH AS AUDITORS FOR FISCAL YEAR 2022 AND FOR THE REVIEW OF INTERIM FINANCIAL STATEMENTS FOR THE FIRST HALF OF FISCAL YEAR 2022

Management

No Action

6.1

ELECT AXEL HERBERG TO THE SUPERVISORY BOARD

Management

No Action

6.2

ELECT ANDREA ABT TO THE SUPERVISORY BOARD

Management

No Action

6.3

ELECT ANNETTE KOEHLER TO THE SUPERVISORY BOARD

Management

No Action

6.4

ELECT KARIN DORREPAAL TO THE SUPERVISORY BOARD

Management

No Action

6.5

ELECT PETER NOE TO THE SUPERVISORY BOARD

Management

No Action

6.6

ELECT UDO VETTER TO THE SUPERVISORY BOARD

Management

No Action

CMMT

28 APR 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO CHANGE IN NUMBERING-OF RESOLUTION 6.6. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE-AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU

Non-Voting

CHINA MENGNIU DAIRY CO LTD

Security

G21096105

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

08-Jun-2022

ISIN

KYG210961051

Agenda

715650075 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0516/2022051600491.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0516/2022051600500.pdf

Non-Voting

CMMT

PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING.

Non-Voting

TO REVIEW AND CONSIDER THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND THE INDEPENDENT AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2021

Management

For

TO APPROVE THE PROPOSED FINAL DIVIDEND OF RMB0.381 PER SHARE FOR THE YEAR ENDED 31 DECEMBER 2021

Management

For

3.A

TO RE-ELECT MR. CHEN LANG AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION

Management

Against

3.B

TO RE-ELECT MS. WANG YAN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HER REMUNERATION

Management

For

3.C

TO RE-ELECT MR. ZHANG PING AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION

Management

For

3.D

TO RE-ELECT MR. WANG XI AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION

Management

For

3.E

TO RE-ELECT MR. YIH DIETER (ALIAS YIH LAI TAK, DIETER) AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION

Management

For

3.F

TO RE-ELECT MR. LI MICHAEL HANKIN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION

Management

For

3.G

TO RE-ELECT MR. GE JUN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION

Management

For

TO APPOINT KPMG AS THE AUDITORS OF THE COMPANY AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THEIR REMUNERATION FOR THE YEAR ENDING 31 DECEMBER 2022

Management

For

ORDINARY RESOLUTION NO. 5 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE SHARES IN THE COMPANY NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY)

Management

For

ORDINARY RESOLUTION NO. 6 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY)

Management

Against

SPECIAL RESOLUTION NO. 7 SET OUT IN THE NOTICE OF AGM (TO APPROVE THE PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF THE COMPANY AND THE ADOPTION OF THE NEW MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF THE COMPANY)

Management

Against

PARATEK PHARMACEUTICALS, INC.

Security

699374302

Meeting Type

Annual

Ticker Symbol

PRTK

Meeting Date

08-Jun-2022

ISIN

US6993743029

Agenda

935613845 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Thomas J. Dietz, Ph.D.

For

Timothy R. Franson M.D.

For

Evan Loh, M.D.

For

To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

2SEVENTY BIO, INC.

Security

901384107

Meeting Type

Annual

Ticker Symbol

TSVT

Meeting Date

08-Jun-2022

ISIN

US9013841070

Agenda

935618871 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Nick Leschly

For

Ramy Ibrahim, M.D.

For

To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

DAVITA INC.

Security

23918K108

Meeting Type

Annual

Ticker Symbol

DVA

Meeting Date

09-Jun-2022

ISIN

US23918K1088

Agenda

935626474 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Pamela M. Arway

Management

For

1b.

Election of Director: Charles G. Berg

Management

For

1c.

Election of Director: Barbara J. Desoer

Management

For

1d.

Election of Director: Paul J. Diaz

Management

For

1e.

Election of Director: Jason M. Hollar

Management

For

1f.

Election of Director: Gregory J. Moore, MD, PhD

Management

For

1g.

Election of Director: John M. Nehra

Management

For

1h.

Election of Director: Javier J. Rodriguez

Management

For

1i.

Election of Director: Phyllis R. Yale

Management

For

To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2022.

Management

For

To approve, on an advisory basis, the compensation of our named executive officers.

Management

For

Stockholder proposal regarding political contributions disclosure, if properly presented at the meeting.

Shareholder

Abstain

Against

SOVOS BRANDS INC.

Security

84612U107

Meeting Type

Annual

Ticker Symbol

SOVO

Meeting Date

09-Jun-2022

ISIN

US84612U1079

Agenda

935627109 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of the Class I Director to serve until the 2025 Annual Meeting: Todd R. Lachman

Management

For

1b.

Election of the Class I Director to serve until the 2025 Annual Meeting: Neha U. Mathur

Management

For

1c.

Election of the Class I Director to serve until the 2025 Annual Meeting: Valarie L. Sheppard

Management

For

Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022

Management

For

SILK ROAD MEDICAL, INC.

Security

82710M100

Meeting Type

Annual

Ticker Symbol

SILK

Meeting Date

09-Jun-2022

ISIN

US82710M1009

Agenda

935628024 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Elizabeth H. Weatherman

For

Donald J. Zurbay

For

To approve Named Executive Officer Compensation on an advisory basis.

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.

Management

For

EXACT SCIENCES CORPORATION

Security

30063P105

Meeting Type

Annual

Ticker Symbol

EXAS

Meeting Date

09-Jun-2022

ISIN

US30063P1057

Agenda

935632629 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Kevin Conroy

For

Shacey Petrovic

For

Katherine Zanotti

For

To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022.

Management

For

To approve, on an advisory basis, the compensation of our named executive officers.

Management

For

To approve Amendment No. 1 to the Exact Sciences Corporation 2019 Omnibus Long-Term Incentive Plan.

Management

Against

To approve the Amended and Restated Exact Sciences Corporation 2010 Employee Stock Purchase Plan.

Management

For

The Shareholder Proposal concerning proxy access.

Shareholder

Abstain

Against

EVOLENT HEALTH, INC.

Security

30050B101

Meeting Type

Annual

Ticker Symbol

EVH

Meeting Date

09-Jun-2022

ISIN

US30050B1017

Agenda

935634142 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Craig Barbarosh

Management

For

1b.

Election of Director: Kim Keck

Management

For

1c.

Election of Director: Cheryl Scott

Management

For

1d.

Election of Director: Frank Williams

Management

For

1e.

Election of Director: Seth Blackley

Management

For

1f.

Election of Director: David Farner

Management

For

1g.

Election of Director: Peter Grua

Management

For

Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Proposal to approve the compensation of our named executive officers for 2021 on an advisory basis.

Management

For

REGENERON PHARMACEUTICALS, INC.

Security

75886F107

Meeting Type

Annual

Ticker Symbol

REGN

Meeting Date

10-Jun-2022

ISIN

US75886F1075

Agenda

935620383 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Bonnie L. Bassler, Ph.D.

Management

For

1b.

Election of Director: Michael S. Brown, M.D.

Management

For

1c.

Election of Director: Leonard S. Schleifer, M.D., Ph.D.

Management

For

1d.

Election of Director: George D. Yancopoulos, M.D., Ph.D.

Management

For

Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Proposal to approve, on an advisory basis, executive compensation.

Management

For

TINGYI (CAYMAN ISLANDS) HOLDING CORP

Security

G8878S103

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

13-Jun-2022

ISIN

KYG8878S1030

Agenda

715578665 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0426/2022042600353.pdf- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0426/2022042600369.pdf

Non-Voting

CMMT

PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING.

Non-Voting

TO RECEIVE AND CONSIDER THE AUDITED ACCOUNTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2021

Management

For

TO APPROVE THE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021

Management

For

TO APPROVE THE PAYMENT OF A SPECIAL FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021

Management

For

TO RE-ELECT MR. YUKO TAKAHASHI AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION

Management

Against

TO RE-ELECT MS. TSENG CHIEN AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HER REMUNERATION

Management

For

TO RE-ELECT MR. HSU, SHIN-CHUN AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION

Management

Against

TO RE-APPOINT AUDITORS OF THE COMPANY AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION

Management

For

TO CONSIDER AND APPROVE THE GENERAL MANDATE TO ISSUE SHARES

Management

Against

TO CONSIDER AND APPROVE THE GENERAL MANDATE TO BUY BACK SHARES OF THE COMPANY

Management

For

TO CONSIDER AND APPROVE THAT THE TOTAL NUMBER OF SHARES WHICH ARE BOUGHT BACK BY THE COMPANY SHALL BE ADDED TO THE TOTAL NUMBER OF SHARES WHICH MAY BE ALLOTED PURSUANT TO THE GENERAL MANDATE FOR ISSUE OF SHARES

Management

Against

TINGYI (CAYMAN ISLANDS) HOLDING CORP

Security

G8878S103

Meeting Type

ExtraOrdinary General Meeting

Ticker Symbol

Meeting Date

13-Jun-2022

ISIN

KYG8878S1030

Agenda

715596536 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

CMMT

PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING.

Non-Voting

CMMT

PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0428/2022042800698.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0428/2022042800822.pdf

Non-Voting

TO APPROVE THE TINGZHENG SUPPLY AGREEMENT, THE TRANSACTIONS CONTEMPLATED THEREUNDER AND THE RELEVANT ANNUAL CAPS

Management

For

TO APPROVE THE MARINE VISION SUPPLY AGREEMENT, THE TRANSACTIONS CONTEMPLATED THEREUNDER AND THE RELEVANT ANNUAL CAPS

Management

For

TO APPROVE THE TING TONG LOGISTICS AGREEMENT, THE TRANSACTIONS CONTEMPLATED THEREUNDER AND THE RELEVANT ANNUAL CAPS

Management

For

GOODRX HOLDINGS, INC.

Security

38246G108

Meeting Type

Annual

Ticker Symbol

GDRX

Meeting Date

14-Jun-2022

ISIN

US38246G1085

Agenda

935623858 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Christopher Adams

For

Trevor Bezdek

For

Adam Karol

For

Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company’s named executive officers.

Management

1 Year

For

GLOBAL BLOOD THERAPEUTICS, INC.

Security

37890U108

Meeting Type

Annual

Ticker Symbol

GBT

Meeting Date

14-Jun-2022

ISIN

US37890U1088

Agenda

935632035 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Ted W. Love, M.D.

For

Glenn F. Pierce, MD PhD

For

Dawn A. Svoronos

For

Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers as disclosed in the proxy statement.

Management

For

Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.

Management

For

INCYTE CORPORATION

Security

45337C102

Meeting Type

Annual

Ticker Symbol

INCY

Meeting Date

15-Jun-2022

ISIN

US45337C1027

Agenda

935620713 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Julian C. Baker

Management

For

1.2

Election of Director: Jean-Jacques Bienaimé

Management

For

1.3

Election of Director: Otis W. Brawley

Management

For

1.4

Election of Director: Paul J. Clancy

Management

For

1.5

Election of Director: Jacqualyn A. Fouse

Management

For

1.6

Election of Director: Edmund P. Harrigan

Management

For

1.7

Election of Director: Katherine A. High

Management

For

1.8

Election of Director: Hervé Hoppenot

Management

For

Approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.

Management

For

Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2022.

Management

For

GUARDANT HEALTH, INC.

Security

40131M109

Meeting Type

Annual

Ticker Symbol

Meeting Date

15-Jun-2022

ISIN

US40131M1099

Agenda

935621424 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1A.

Election of Class I Director: Vijaya Gadde

Management

For

1B.

Election of Class I Director: Myrtle Potter

Management

For

Ratification of the appointment of Ernst & Young LLP as Guardant Health, Inc.’s independent registered public accounting firm for the year ending December 31, 2022.

Management

For

Non-binding advisory vote to approve Guardant Health, Inc.’s named executive officer compensation.

Management

For

CAREDX, INC.

Security

14167L103

Meeting Type

Annual

Ticker Symbol

CDNA

Meeting Date

15-Jun-2022

ISIN

US14167L1035

Agenda

935629999 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Fred E Cohen MD, DPhil

For

Christine M. Cournoyer

For

William A. Hagstrom

For

Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.

Management

For

Approval, on an advisory basis, of the compensation of our named executive officers.

Management

For

EHEALTH, INC.

Security

28238P109

Meeting Type

Annual

Ticker Symbol

EHTH

Meeting Date

15-Jun-2022

ISIN

US28238P1093

Agenda

935634952 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

A. John Hass

For

Francis S. Soistman

For

Aaron C. Tolson

For

Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of eHealth, Inc. for the fiscal year ending December 31, 2022.

Management

For

Approval, on an advisory basis, of the compensation of the Named Executive Officers of eHealth, Inc.

Management

For

Approval of an amendment to eHealth, Inc.’s 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 3,000,000 shares.

Management

Against

CUTERA, INC.

Security

232109108

Meeting Type

Annual

Ticker Symbol

CUTR

Meeting Date

15-Jun-2022

ISIN

US2321091082

Agenda

935636677 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Gregory A. Barrett

Management

For

1b.

Election of Director: Sheila A. Hopkins

Management

For

1c.

Election of Director: David H. Mowry

Management

For

1d.

Election of Director: Timothy J. O’Shea

Management

For

1e.

Election of Director: Juliane T. Park

Management

For

1f.

Election of Director: J. Daniel Plants

Management

For

1g.

Election of Director: Joseph E. Whitters

Management

For

1h.

Election of Director: Janet L. Widmann

Management

For

1i.

Election of Director: Katherine S. Zanotti

Management

For

Ratification of BDO USA, LLP as the Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2022.

Management

For

Non-binding advisory vote on the compensation of Named Executive Officers.

Management

For

Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 600,000 shares.

Management

Against

STANDARD BIOTOOLS INC.

Security

34385P108

Meeting Type

Annual

Ticker Symbol

LAB

Meeting Date

15-Jun-2022

ISIN

US34385P1084

Agenda

935637845 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Laura M. Clague

For

Frank Witney

For

To approve our executive compensation program for the year ended December 31, 2021, on an advisory (non- binding) basis.

Management

For

To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

GRITSTONE BIO, INC.

Security

39868T105

Meeting Type

Annual

Ticker Symbol

GRTS

Meeting Date

17-Jun-2022

ISIN

US39868T1051

Agenda

935626234 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Andrew Allen, M.D., PhD

For

Naiyer Rizvi, M.D.

For

The ratification of the selection, by the audit committee of our board of directors, of Ernst & Young LLP, as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

NANOSTRING TECHNOLOGIES, INC.

Security

63009R109

Meeting Type

Annual

Ticker Symbol

NSTG

Meeting Date

17-Jun-2022

ISIN

US63009R1095

Agenda

935638289 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Dana Rollison, Ph.D.

For

William D. Young

For

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022.

Management

For

To approve, on an advisory basis, the compensation of our named executive officers.

Management

For

To approve the NanoString Technologies, Inc. 2022 Equity Incentive Plan.

Management

Against

To approve, on an advisory basis, a stockholder proposal to elect each director annually.

Shareholder

Abstain

KIKKOMAN CORPORATION

Security

J32620106

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

21-Jun-2022

ISIN

JP3240400006

Agenda

715716974 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Please reference meeting materials.

Non-Voting

Approve Appropriation of Surplus

Management

For

Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations

Management

For

3.1

Appoint a Director Mogi, Yuzaburo

Management

Against

3.2

Appoint a Director Horikiri, Noriaki

Management

For

3.3

Appoint a Director Nakano, Shozaburo

Management

For

3.4

Appoint a Director Yamazaki, Koichi

Management

For

3.5

Appoint a Director Shimada, Masanao

Management

For

3.6

Appoint a Director Mogi, Osamu

Management

For

3.7

Appoint a Director Matsuyama, Asahi

Management

For

3.8

Appoint a Director Kamiyama, Takao

Management

For

3.9

Appoint a Director Fukui, Toshihiko

Management

For

3.10

Appoint a Director Inokuchi, Takeo

Management

For

3.11

Appoint a Director Iino, Masako

Management

For

3.12

Appoint a Director Sugiyama, Shinsuke

Management

For

Appoint a Corporate Auditor Kajikawa, Toru

Management

For

Appoint a Substitute Corporate Auditor Endo, Kazuyoshi

Management

For

Approve Details of the Compensation to be received by Corporate Officers

Management

For

Approve Details of the Stock Compensation to be received by Directors

Management

For

Approve Delegation of Authority to the Board of Directors to Use Free Share Acquisition Rights

Management

Against

VAPOTHERM, INC.

Security

922107107

Meeting Type

Annual

Ticker Symbol

VAPO

Meeting Date

21-Jun-2022

ISIN

US9221071072

Agenda

935641022 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director to serve until the 2025 annual meeting: Joseph Army

Management

For

1.2

Election of Director to serve until the 2025 annual meeting: James Liken

Management

For

1.3

Election of Director to serve until the 2025 annual meeting: Elizabeth Weatherman

Management

For

To approve, on an advisory (non-binding) basis, our executive compensation.

Management

For

To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.

Management

For

BAUSCH HEALTH COMPANIES, INC.

Security

071734107

Meeting Type

Annual

Ticker Symbol

BHC

Meeting Date

21-Jun-2022

ISIN

CA0717341071

Agenda

935644838 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Thomas J. Appio

Management

For

1b.

Election of Director: Richard U. De Schutter

Management

For

1c.

Election of Director: Brett Icahn

Management

For

1d.

Election of Director: Dr. Argeris (Jerry) N. Karabelas

Management

For

1e.

Election of Director: Sarah B. Kavanagh

Management

For

1f.

Election of Director: Steven D. Miller

Management

For

1g.

Election of Director: Dr. Richard C. Mulligan

Management

For

1h.

Election of Director: Joseph C. Papa

Management

For

1i.

Election of Director: Robert N. Power

Management

For

1j.

Election of Director: Russel C. Robertson

Management

For

1k.

Election of Director: Thomas W. Ross, Sr.

Management

For

1l.

Election of Director: Amy B. Wechsler, M.D.

Management

For

The approval, in an advisory vote, of the compensation of our Named Executive Officers.

Management

For

The approval of an amendment and restatement of the Company’s Amended and Restated 2014 Omnibus Incentive Plan.

Management

Withheld

Against

The appointment of PricewaterhouseCoopers LLP to serve as the Company’s auditor until the close of the 2023 Annual Meeting of Shareholders and to authorize the Board to fix the auditor’s remuneration.

Management

For

YAKULT HONSHA CO.,LTD.

Security

J95468120

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

22-Jun-2022

ISIN

JP3931600005

Agenda

715727876 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Please reference meeting materials.

Non-Voting

Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations

Management

For

2.1

Appoint a Director Narita, Hiroshi

Management

For

2.2

Appoint a Director Wakabayashi, Hiroshi

Management

For

2.3

Appoint a Director Ishikawa, Fumiyasu

Management

For

2.4

Appoint a Director Doi, Akifumi

Management

For

2.5

Appoint a Director Hayashida, Tetsuya

Management

For

2.6

Appoint a Director Ito, Masanori

Management

For

2.7

Appoint a Director Hirano, Susumu

Management

For

2.8

Appoint a Director Imada, Masao

Management

For

2.9

Appoint a Director Hirano, Koichi

Management

For

2.10

Appoint a Director Yasuda, Ryuji

Management

For

2.11

Appoint a Director Tobe, Naoko

Management

For

2.12

Appoint a Director Shimbo, Katsuyoshi

Management

For

2.13

Appoint a Director Nagasawa, Yumiko

Management

For

2.14

Appoint a Director Naito, Manabu

Management

For

2.15

Appoint a Director Akutsu, Satoshi

Management

For

BLUEBIRD BIO, INC.

Security

09609G100

Meeting Type

Annual

Ticker Symbol

BLUE

Meeting Date

22-Jun-2022

ISIN

US09609G1004

Agenda

935641123 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Class III Director: Nick Leschly

Management

For

1b.

Election of Class III Director: Najoh Tita-Reid

Management

For

To approve, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers.

Management

For

To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

PETIQ, INC.

Security

71639T106

Meeting Type

Annual

Ticker Symbol

PETQ

Meeting Date

22-Jun-2022

ISIN

US71639T1060

Agenda

935646301 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Class II Director to serve until the third Annual Meeting: Larry Bird

Management

Abstain

Against

1b.

Election of Class II Director to serve until the third Annual Meeting: Mark First

Management

For

1c.

Election of Class II Director to serve until the third Annual Meeting: Scott Huff

Management

For

To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

Management

For

To approve, on an advisory, non-binding basis, the compensation of our named executive officers.

Management

For

To approve the amendment and restatement of our Amended and Restated 2017 Omnibus Incentive Plan.

Management

Against

To amend our Amended and Restated Certificate of Incorporation to eliminate supermajority provisions.

Management

For

To amend our Amended and Restated Certificate of Incorporation to declassify our Board of Directors.

Management

For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security

881624209

Meeting Type

Annual

Ticker Symbol

TEVA

Meeting Date

23-Jun-2022

ISIN

US8816242098

Agenda

935630978 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Amir Elstein

Management

For

1b.

Election of Director: Roberto A. Mignone

Management

For

1c.

Election of Director: Dr. Perry D. Nisen

Management

For

1d.

Election of Director: Dr. Tal Zaks

Management

For

To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers.

Management

For

To approve Teva’s Compensation Policy with respect to the Terms of Office and Employment of Teva’s Executive Officers and Directors.

Management

For

3A.

Regarding proposal 3, please indicate when you vote whether or not you are a controlling shareholder of Teva and whether or not you have a personal benefit or other interest in this proposal* Mark “for” = yes or “against” = no.

Management

Against

To approve amendments to Teva’s Articles of Association.

Management

For

To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva’s independent registered public accounting firm until Teva’s 2023 annual meeting of shareholders.

Management

For

THE KROGER CO.

Security

501044101

Meeting Type

Annual

Ticker Symbol

Meeting Date

23-Jun-2022

ISIN

US5010441013

Agenda

935647416 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Nora A. Aufreiter

For

Kevin M. Brown

For

Elaine L. Chao

For

Anne Gates

For

Karen M. Hoguet

For

W. Rodney McMullen

For

Clyde R. Moore

For

Ronald L. Sargent

For

J. Amanda Sourry Knox

For

Mark S. Sutton

For

Ashok Vemuri

For

To approve our executive compensation, on an advisory basis

Management

For

To ratify the selection of our independent auditor for fiscal year 2022

Management

For

To approve additional shares under the 2019 Long-Term Incentive Plan

Management

Against

Shareholder Proposal - Recyclability of Packaging

Shareholder

Abstain

Against

Shareholder Proposal - Report on Protection of Farmworkers

Shareholder

Abstain

Against

Shareholder Proposal - Report on Elimination of HFCs

Shareholder

Abstain

Against

Shareholder Proposal - Report on Workforce Strategy

Shareholder

Abstain

Against

ORGANOGENESIS HOLDINGS INC

Security

68621F102

Meeting Type

Annual

Ticker Symbol

ORGO

Meeting Date

23-Jun-2022

ISIN

US68621F1021

Agenda

935654752 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

DIRECTOR

Management

Alan A. Ades

For

Robert Ades

For

Michael J. Driscoll

For

Prathyusha Duraibabu

For

David Erani

For

Jon Giacomin

For

Gary S. Gillheeney, Sr.

For

Michele Korfin

For

Arthur S. Leibowitz

For

Glenn H. Nussdorf

For

Gilberto Quintero

For

Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company’s proxy statement for its 2022 annual meeting of shareholders.

Management

For

Approval, on an advisory basis, of the frequency of holding an advisory vote on the compensation paid to our named executive officers.

Management

1 Year

For

Approval of an amendment to our certificate of incorporation to remove a provision that states that directors may only be removed for cause.

Management

For

Approval of an amendment to our 2018 Equity Incentive Plan to increase the number of shares of Class A common stock reserved for issuance thereunder by 7,826,970 shares.

Management

Against

Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2022.

Management

For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security

881624209

Meeting Type

Annual

Ticker Symbol

TEVA

Meeting Date

23-Jun-2022

ISIN

US8816242098

Agenda

935657859 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1a.

Election of Director: Amir Elstein

Management

For

1b.

Election of Director: Roberto A. Mignone

Management

For

1c.

Election of Director: Dr. Perry D. Nisen

Management

For

1d.

Election of Director: Dr. Tal Zaks

Management

For

To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers.

Management

For

To approve Teva’s Compensation Policy with respect to the Terms of Office and Employment of Teva’s Executive Officers and Directors.

Management

For

3A.

Management

Against

To approve amendments to Teva’s Articles of Association.

Management

For

To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva’s independent registered public accounting firm until Teva’s 2023 annual meeting of shareholders.

Management

For

MORINAGA MILK INDUSTRY CO.,LTD.

Security

J46410114

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

29-Jun-2022

ISIN

JP3926800008

Agenda

715745761 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Please reference meeting materials.

Non-Voting

Approve Appropriation of Surplus

Management

For

Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations

Management

For

3.1

Appoint a Director Miyahara, Michio

Management

For

3.2

Appoint a Director Onuki, Yoichi

Management

For

3.3

Appoint a Director Okawa, Teiichiro

Management

For

3.4

Appoint a Director Minato, Tsuyoshi

Management

For

3.5

Appoint a Director Yanagida, Yasuhiko

Management

For

3.6

Appoint a Director Hyodo, Hitoshi

Management

For

3.7

Appoint a Director Nozaki, Akihiro

Management

For

3.8

Appoint a Director Yoneda, Takatomo

Management

For

3.9

Appoint a Director Tominaga, Yukari

Management

For

3.10

Appoint a Director Nakamura, Hiroshi

Management

For

3.11

Appoint a Director Ikeda, Takayuki

Management

For

Appoint a Corporate Auditor Hirota, Keiki

Management

Against

Appoint a Substitute Corporate Auditor Suzuki, Michio

Management

For

MEIJI HOLDINGS CO.,LTD.

Security

J41729104

Meeting Type

Annual General Meeting

Ticker Symbol

Meeting Date

29-Jun-2022

ISIN

JP3918000005

Agenda

715745773 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

Please reference meeting materials.

Non-Voting

Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations

Management

For

2.1

Appoint a Director Kawamura, Kazuo

Management

For

2.2

Appoint a Director Kobayashi, Daikichiro

Management

For

2.3

Appoint a Director Matsuda, Katsunari

Management

For

2.4

Appoint a Director Shiozaki, Koichiro

Management

For

2.5

Appoint a Director Furuta, Jun

Management

For

2.6

Appoint a Director Matsumura, Mariko

Management

For

2.7

Appoint a Director Kawata, Masaya

Management

For

2.8

Appoint a Director Kuboyama, Michiko

Management

For

2.9

Appoint a Director Peter D. Pedersen

Management

For

Appoint a Substitute Corporate Auditor Imamura, Makoto

Management

For

ODONATE THERAPEUTICS, INC.

Security

676079106

Meeting Type

Annual

Ticker Symbol

ODTC

Meeting Date

30-Jun-2022

ISIN

US6760791060

Agenda

935674639 - Management

Item

Proposal

Proposed
by

Vote

For/Against
Management

1.1

Election of Director: Kevin Tang

Management

Abstain

Against

1.2

Election of Director: Aaron Davis

Management

Abstain

Against

1.3

Election of Director: Craig Johnson

Management

Abstain

Against

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Registrant

The Gabelli Healthcare & Wellness^Rx Trust

By (Signature and Title)*	/s/ John C. Ball
	John C. Ball, President and Principal Executive Officer

Date	August 24, 2022

*Print the name and title of each signing officer under his or her signature.

The Gabelli Healthcare & Wellness Trust (GRX) N-PXAnnual report of proxy voting record